{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:35:07Z","timestamp":1794623707606,"version":"4.9.1"},"reference-count":496,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82273862"],"award-info":[{"award-number":["No. 82273862"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82574335"],"award-info":[{"award-number":["No. 82574335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82404520"],"award-info":[{"award-number":["No. 82404520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752834"],"award-info":[{"award-number":["2024M752834"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China National Postdoctoral Program for Innovative Talents"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02910-2","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:01:35Z","timestamp":1788220895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Regulatory T cell induction strategies and applications in the treatment of immune and non-immune diseases"],"prefix":"10.1038","volume":"11","author":[{"given":"Yaqi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7114-6299","authenticated-orcid":false,"given":"Jian","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"2910_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-immunol-100219-020937","volume":"38","author":"PA Savage","year":"2020","unstructured":"Savage, P. A., Klawon, D. E. J. & Miller, C. H. Regulatory T cell development. Annu. Rev. Immunol. 38, 421\u2013453 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"2910_CR2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1126\/science.166.3906.753","volume":"166","author":"Y Nishizuka","year":"1969","unstructured":"Nishizuka, Y. & Sakakura, T. Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166, 753\u2013755 (1969).","journal-title":"Science"},{"key":"2910_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03896-z","volume":"21","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Cholesterol suppresses human iTreg differentiation and nTreg function through mitochondria-related mechanisms. J. Transl. Med. 21, 224 (2023).","journal-title":"J. Transl. Med."},{"key":"2910_CR4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.immuni.2022.05.010","volume":"55","author":"J van der Veeken","year":"2022","unstructured":"van der Veeken, J. et al. Genetic tracing reveals transcription factor Foxp3-dependent and Foxp3-independent functionality of peripherally induced Treg cells. Immunity 55, 1173\u20131184.e1177 (2022).","journal-title":"Immunity"},{"key":"2910_CR5","doi-asserted-by":"publisher","first-page":"1166135","DOI":"10.3389\/fimmu.2023.1166135","volume":"14","author":"JA Bluestone","year":"2023","unstructured":"Bluestone, J. A., McKenzie, B. S., Beilke, J. & Ramsdell, F. Opportunities for Treg cell therapy for the treatment of human disease. Front. Immunol. 14, 1166135 (2023).","journal-title":"Front. Immunol."},{"key":"2910_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","volume":"38","author":"S Sakaguchi","year":"2020","unstructured":"Sakaguchi, S. et al. Regulatory T cells and human disease. Annu. Rev. Immunol. 38, 541\u2013566 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"2910_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.1160062","volume":"322","author":"K Wing","year":"2008","unstructured":"Wing, K. et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271\u2013275 (2008).","journal-title":"Science"},{"key":"2910_CR8","doi-asserted-by":"publisher","first-page":"e2023739118","DOI":"10.1073\/pnas.2023739118","volume":"118","author":"M Tekguc","year":"2021","unstructured":"Tekguc, M. et al. Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells. Proc. Natl. Acad. Sci. USA. 118, e2023739118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR9","doi-asserted-by":"publisher","first-page":"103085","DOI":"10.1016\/j.autrev.2022.103085","volume":"21","author":"S Gertel","year":"2022","unstructured":"Gertel, S., Polachek, A., Elkayam, O. & Furer, V. Lymphocyte activation gene-3 (LAG-3) regulatory T cells: an evolving biomarker for treatment response in autoimmune diseases. Autoimmun. Rev. 21, 103085 (2022).","journal-title":"Autoimmun. Rev."},{"key":"2910_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2004.08.010","volume":"21","author":"CT Huang","year":"2004","unstructured":"Huang, C. T. et al. Role of LAG-3 in regulatory T cells. Immunity 21, 503\u2013513 (2004).","journal-title":"Immunity"},{"key":"2910_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41590-018-0280-2","volume":"20","author":"B Akkaya","year":"2019","unstructured":"Akkaya, B. et al. Regulatory T cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells. Nat. Immunol. 20, 218\u2013231 (2019).","journal-title":"Nat. Immunol."},{"key":"2910_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","volume":"27","author":"X Cao","year":"2007","unstructured":"Cao, X. et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27, 635\u2013646 (2007).","journal-title":"Immunity"},{"key":"2910_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","volume":"28","author":"YP Rubtsov","year":"2008","unstructured":"Rubtsov, Y. P. et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546\u2013558 (2008).","journal-title":"Immunity"},{"key":"2910_CR14","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni.1952","volume":"11","author":"LW Collison","year":"2010","unstructured":"Collison, L. W. et al. IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11, 1093\u20131101 (2010).","journal-title":"Nat. Immunol."},{"key":"2910_CR15","doi-asserted-by":"publisher","first-page":"8068","DOI":"10.3390\/ijms22158068","volume":"22","author":"E Timperi","year":"2021","unstructured":"Timperi, E. & Barnaba, V. CD39 regulation and functions in T cells. Int. J. Mol. Sci. 22, 8068 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2910_CR16","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino, G. et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225\u20131232 (2007).","journal-title":"Blood"},{"key":"2910_CR17","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/ni.3540","volume":"17","author":"T Chinen","year":"2016","unstructured":"Chinen, T. et al. An essential role for the IL-2 receptor in T(reg) cell function. Nat. Immunol. 17, 1322\u20131333 (2016).","journal-title":"Nat. Immunol."},{"key":"2910_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","volume":"42","author":"MF Cusick","year":"2012","unstructured":"Cusick, M. F., Libbey, J. E. & Fujinami, R. S. Molecular mimicry as a mechanism of autoimmune disease. Clin. Rev. Allergy Immunol. 42, 102\u2013111 (2012).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"2910_CR19","doi-asserted-by":"publisher","first-page":"eadk3248","DOI":"10.1126\/science.adk3248","volume":"387","author":"DEJ Klawon","year":"2025","unstructured":"Klawon, D. E. J. et al. Regulatory T cells constrain T cells of shared specificity to enforce tolerance during infection. Science 387, eadk3248 (2025).","journal-title":"Science"},{"key":"2910_CR20","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nm.2002","volume":"15","author":"M Feuerer","year":"2009","unstructured":"Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930\u2013939 (2009).","journal-title":"Nat. Med."},{"key":"2910_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-immunol-032712-095948","volume":"34","author":"M Panduro","year":"2016","unstructured":"Panduro, M., Benoist, C. & Mathis, D. Tissue Tregs. Annu. Rev. Immunol. 34, 609\u2013633 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"2910_CR22","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","volume":"155","author":"D Burzyn","year":"2013","unstructured":"Burzyn, D. et al. A special population of regulatory T cells potentiates muscle repair. Cell 155, 1282\u20131295 (2013).","journal-title":"Cell"},{"key":"2910_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.immuni.2016.01.009","volume":"44","author":"W Kuswanto","year":"2016","unstructured":"Kuswanto, W. et al. Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent accumulation of regulatory T cells. Immunity 44, 355\u2013367 (2016).","journal-title":"Immunity"},{"key":"2910_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12160","volume":"259","author":"EM Shevach","year":"2014","unstructured":"Shevach, E. M. & Thornton, A. M. tTregs, pTregs, and iTregs: similarities and differences. Immunol. Rev. 259, 88\u2013102 (2014).","journal-title":"Immunol. Rev."},{"key":"2910_CR25","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1084\/jem.156.6.1565","volume":"156","author":"S Sakaguchi","year":"1982","unstructured":"Sakaguchi, S., Takahashi, T. & Nishizuka, Y. Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J. Exp. Med. 156, 1565\u20131576 (1982).","journal-title":"J. Exp. Med."},{"key":"2910_CR26","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi, S. et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151\u20131164 (1995).","journal-title":"J. Immunol."},{"key":"2910_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4419-1599-3_2","volume":"665","author":"CH Kim","year":"2009","unstructured":"Kim, C. H. FOXP3 and its role in the immune system. Adv. Exp. Med. Biol. 665, 17\u201329 (2009).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2910_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett, C. L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20\u201321 (2001).","journal-title":"Nat. Genet."},{"key":"2910_CR29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057\u20131061 (2003).","journal-title":"Science"},{"key":"2910_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330\u2013336 (2003).","journal-title":"Nat. Immunol."},{"key":"2910_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ni909","volume":"4","author":"R Khattri","year":"2003","unstructured":"Khattri, R., Cox, T., Yasayko, S. A. & Ramsdell, F. An essential role for Scurfin in CD4+CD25+T regulatory cells. Nat. Immunol. 4, 337\u2013342 (2003).","journal-title":"Nat. Immunol."},{"key":"2910_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ni1437","volume":"8","author":"LM Williams","year":"2007","unstructured":"Williams, L. M. & Rudensky, A. Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8, 277\u2013284 (2007).","journal-title":"Nat. Immunol."},{"key":"2910_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/imm.13520","volume":"168","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Human FOXP3 and tumour microenvironment. Immunology 168, 248\u2013255 (2023).","journal-title":"Immunology"},{"key":"2910_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","volume":"24","author":"TS Sumida","year":"2024","unstructured":"Sumida, T. S., Cheru, N. T. & Hafler, D. A. The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases. Nat. Rev. Immunol. 24, 503\u2013517 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"2910_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08960-1","volume":"10","author":"KH Toomer","year":"2019","unstructured":"Toomer, K. H. et al. Essential and non-overlapping IL-2R\u03b1-dependent processes for thymic development and peripheral homeostasis of regulatory T cells. Nat. Commun. 10, 1037 (2019).","journal-title":"Nat. Commun."},{"key":"2910_CR36","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.immuni.2021.03.020","volume":"54","author":"S Dikiy","year":"2021","unstructured":"Dikiy, S. et al. A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance. Immunity 54, 931\u2013946.e911 (2021).","journal-title":"Immunity"},{"key":"2910_CR37","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.immuni.2021.04.005","volume":"54","author":"R Kawakami","year":"2021","unstructured":"Kawakami, R. et al. Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells. Immunity 54, 947\u2013961.e948 (2021).","journal-title":"Immunity"},{"key":"2910_CR38","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s44319-024-00070-4","volume":"25","author":"S Tang","year":"2024","unstructured":"Tang, S. et al. A lncRNA Dleu2-encoded peptide relieves autoimmunity by facilitating Smad3-mediated Treg induction. EMBO Rep. 25, 1208\u20131232 (2024).","journal-title":"EMBO Rep."},{"key":"2910_CR39","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1084\/jem.20112646","volume":"209","author":"SM Schlenner","year":"2012","unstructured":"Schlenner, S. M. et al. Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut. J. Exp. Med. 209, 1529\u20131535 (2012).","journal-title":"J. Exp. Med."},{"key":"2910_CR40","doi-asserted-by":"publisher","first-page":"eadj5789","DOI":"10.1126\/sciimmunol.adj5789","volume":"8","author":"A Kaminski","year":"2023","unstructured":"Kaminski, A. et al. Resident regulatory T cells reflect the immune history of individual lymph nodes. Sci. Immunol. 8, eadj5789 (2023).","journal-title":"Sci. Immunol."},{"key":"2910_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.imlet.2022.06.005","volume":"248","author":"A Liston","year":"2022","unstructured":"Liston, A., Dooley, J. & Yshii, L. Brain-resident regulatory T cells and their role in health and disease. Immunol. Lett. 248, 26\u201330 (2022).","journal-title":"Immunol. Lett."},{"key":"2910_CR42","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41577-023-00890-w","volume":"23","author":"D Ramanan","year":"2023","unstructured":"Ramanan, D. et al. Regulatory T cells in the face of the intestinal microbiota. Nat. Rev. Immunol. 23, 749\u2013762 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"2910_CR43","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/eji.201847935","volume":"49","author":"AM Thornton","year":"2019","unstructured":"Thornton, A. M. et al. Helios(+) and Helios(-) Treg subpopulations are phenotypically and functionally distinct and express dissimilar TCR repertoires. Eur. J. Immunol. 49, 398\u2013412 (2019).","journal-title":"Eur. J. Immunol."},{"key":"2910_CR44","doi-asserted-by":"publisher","first-page":"e12237","DOI":"10.1002\/jev2.12237","volume":"11","author":"M Campos-Mora","year":"2022","unstructured":"Campos-Mora, M. et al. Neuropilin-1 is present on Foxp3+ T regulatory cell-derived small extracellular vesicles and mediates immunity against skin transplantation. J. Extracell. Vesicles 11, e12237 (2022).","journal-title":"J. Extracell. Vesicles"},{"key":"2910_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ni.3053","volume":"16","author":"F Yu","year":"2015","unstructured":"Yu, F. et al. Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance. Nat. Immunol. 16, 197\u2013206 (2015).","journal-title":"Nat. Immunol."},{"key":"2910_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nature07674","volume":"458","author":"Y Zheng","year":"2009","unstructured":"Zheng, Y. et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458, 351\u2013356 (2009).","journal-title":"Nature"},{"key":"2910_CR47","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.3389\/fimmu.2018.02075","volume":"9","author":"Q Zeng","year":"2018","unstructured":"Zeng, Q. et al. A unique population: adipose-resident regulatory T cells. Front. Immunol. 9, 2075 (2018).","journal-title":"Front. Immunol."},{"key":"2910_CR48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nature16151","volume":"528","author":"SP Bapat","year":"2015","unstructured":"Bapat, S. P. et al. Depletion of fat-resident Treg cells prevents age-associated insulin resistance. Nature 528, 137\u2013141 (2015).","journal-title":"Nature"},{"key":"2910_CR49","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature11132","volume":"486","author":"D Cipolletta","year":"2012","unstructured":"Cipolletta, D. et al. PPAR-\u03b3 is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486, 549\u2013553 (2012).","journal-title":"Nature"},{"key":"2910_CR50","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nm.2389","volume":"17","author":"M Dominguez-Villar","year":"2011","unstructured":"Dominguez-Villar, M., Baecher-Allan, C. M. & Hafler, D. A. Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat. Med. 17, 673\u2013675 (2011).","journal-title":"Nat. Med."},{"key":"2910_CR51","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1182\/blood-2012-08-443473","volume":"121","author":"AM Pesenacker","year":"2013","unstructured":"Pesenacker, A. M. et al. CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. Blood 121, 2647\u20132658 (2013).","journal-title":"Blood"},{"key":"2910_CR52","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","volume":"5","author":"S Floess","year":"2007","unstructured":"Floess, S. et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, e38 (2007).","journal-title":"PLoS Biol."},{"key":"2910_CR53","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41590-018-0230-z","volume":"19","author":"GAM Povoleri","year":"2018","unstructured":"Povoleri, G. A. M. et al. Human retinoic acid-regulated CD161(+) regulatory T cells support wound repair in intestinal mucosa. Nat. Immunol. 19, 1403\u20131414 (2018).","journal-title":"Nat. Immunol."},{"key":"2910_CR54","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1158\/1078-0432.CCR-22-0977","volume":"28","author":"X Tang","year":"2022","unstructured":"Tang, X. et al. Phenotype, function, and clinical significance of CD26+ and CD161+Tregs in splenic marginal zone lymphoma. Clin. Cancer Res. 28, 4322\u20134335 (2022).","journal-title":"Clin. Cancer Res."},{"key":"2910_CR55","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.immuni.2025.02.011","volume":"58","author":"T Neuwirth","year":"2025","unstructured":"Neuwirth, T. et al. The polyamine-regulating enzyme SSAT1 impairs tissue regulatory T cell function in chronic cutaneous inflammation. Immunity 58, 632\u2013647.e612 (2025).","journal-title":"Immunity"},{"key":"2910_CR56","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","volume":"8","author":"F Shan","year":"2022","unstructured":"Shan, F. et al. Therapeutic targeting of regulatory T cells in cancer. Trends Cancer 8, 944\u2013961 (2022).","journal-title":"Trends Cancer"},{"key":"2910_CR57","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.immuni.2011.12.012","volume":"36","author":"T Miyao","year":"2012","unstructured":"Miyao, T. et al. Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36, 262\u2013275 (2012).","journal-title":"Immunity"},{"key":"2910_CR58","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/eji.200636435","volume":"37","author":"J Wang","year":"2007","unstructured":"Wang, J. et al. Transient expression of FOXP3 in human activated nonregulatory CD4+T cells. Eur. J. Immunol. 37, 129\u2013138 (2007).","journal-title":"Eur. J. Immunol."},{"key":"2910_CR59","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/intimm\/dxm014","volume":"19","author":"SE Allan","year":"2007","unstructured":"Allan, S. E. et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19, 345\u2013354 (2007).","journal-title":"Int. Immunol."},{"key":"2910_CR60","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1182\/blood-2007-06-094656","volume":"110","author":"DQ Tran","year":"2007","unstructured":"Tran, D. Q., Ramsey, H. & Shevach, E. M. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110, 2983\u20132990 (2007).","journal-title":"Blood"},{"key":"2910_CR61","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41590-021-00910-8","volume":"22","author":"D Zemmour","year":"2021","unstructured":"Zemmour, D. et al. Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4(+) T cell perturbations. Nat. Immunol. 22, 607\u2013619 (2021).","journal-title":"Nat. Immunol."},{"key":"2910_CR62","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","volume":"49","author":"MG Roncarolo","year":"2018","unstructured":"Roncarolo, M. G. et al. The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases. Immunity 49, 1004\u20131019 (2018).","journal-title":"Immunity"},{"key":"2910_CR63","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nm.3179","volume":"19","author":"N Gagliani","year":"2013","unstructured":"Gagliani, N. et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 19, 739\u2013746 (2013).","journal-title":"Nat. Med."},{"key":"2910_CR64","doi-asserted-by":"publisher","first-page":"e47121","DOI":"10.15252\/embr.201847121","volume":"20","author":"M Raverdeau","year":"2019","unstructured":"Raverdeau, M. et al. Retinoic acid-induced autoantigen-specific type 1 regulatory T cells suppress autoimmunity. EMBO Rep. 20, e47121 (2019).","journal-title":"EMBO Rep."},{"key":"2910_CR65","doi-asserted-by":"publisher","first-page":"108919","DOI":"10.1016\/j.celrep.2021.108919","volume":"34","author":"CS Umeshappa","year":"2021","unstructured":"Umeshappa, C. S. et al. Liver-specific T regulatory type-1 cells program local neutrophils to suppress hepatic autoimmunity via CRAMP. Cell Rep. 34, 108919 (2021).","journal-title":"Cell Rep."},{"key":"2910_CR66","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41586-024-07752-y","volume":"632","author":"H Sultan","year":"2024","unstructured":"Sultan, H. et al. Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy. Nature 632, 182\u2013191 (2024).","journal-title":"Nature"},{"key":"2910_CR67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","volume":"33","author":"TR Malek","year":"2010","unstructured":"Malek, T. R. & Castro, I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33, 153\u2013165 (2010).","journal-title":"Immunity"},{"key":"2910_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12865-022-00517-0","volume":"23","author":"B Ju","year":"2022","unstructured":"Ju, B. et al. The proportion and phenotypic changes of CD4(+)CD25(-)Foxp3(+) T cells in patients with untreated rheumatoid arthritis. BMC Immunol. 23, 41 (2022).","journal-title":"BMC Immunol."},{"key":"2910_CR69","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.intimp.2011.05.018","volume":"11","author":"X Chen","year":"2011","unstructured":"Chen, X. & Oppenheim, J. J. Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells. Int. Immunopharmacol. 11, 1489\u20131496 (2011).","journal-title":"Int. Immunopharmacol."},{"key":"2910_CR70","doi-asserted-by":"crossref","unstructured":"Luo, S. et al. Foxp3(+)CD8(+) regulatory T cells: bona fide Tregs with cytotoxic function. Trends Immunol. 46, 324\u2013337 (2025).","DOI":"10.1016\/j.it.2025.02.010"},{"key":"2910_CR71","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","volume":"203","author":"W Liu","year":"2006","unstructured":"Liu, W. et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+T reg cells. J. Exp. Med. 203, 1701\u20131711 (2006).","journal-title":"J. Exp. Med."},{"key":"2910_CR72","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/phpp.12643","volume":"37","author":"MS Kim","year":"2021","unstructured":"Kim, M. S. et al. A comparison on viability between CD4+T cells and CD4+CD25+CD127- regulatory T cells by excimer laser in the peripheral blood in vitro. Photodermatol. Photoimmunol. Photomed. 37, 247\u2013249 (2021).","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"2910_CR73","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/art.39408","volume":"68","author":"GJ Walter","year":"2016","unstructured":"Walter, G. J. et al. Phenotypic, functional, and gene expression profiling of peripheral CD45RA+ and CD45RO+CD4+CD25+CD127(low) Treg cells in patients with chronic rheumatoid arthritis. Arthritis Rheumatol. 68, 103\u2013116 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"2910_CR74","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1084\/jem.20060468","volume":"203","author":"N Seddiki","year":"2006","unstructured":"Seddiki, N. et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203, 1693\u20131700 (2006).","journal-title":"J. Exp. Med."},{"key":"2910_CR75","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1073\/pnas.1604765113","volume":"113","author":"H Nakagawa","year":"2016","unstructured":"Nakagawa, H. et al. Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity. Proc. Natl. Acad. Sci. USA. 113, 6248\u20136253 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR76","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/eji.202149318","volume":"52","author":"AJ Lam","year":"2022","unstructured":"Lam, A. J., Uday, P., Gillies, J. K. & Levings, M. K. Helios is a marker, not a driver, of human Treg stability. Eur. J. Immunol. 52, 75\u201384 (2022).","journal-title":"Eur. J. Immunol."},{"key":"2910_CR77","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/art.39091","volume":"67","author":"H Takatori","year":"2015","unstructured":"Takatori, H. et al. Helios enhances Treg cell function in cooperation with FoxP3. Arthritis Rheumatol. 67, 1491\u20131502 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"2910_CR78","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1126\/science.aad0616","volume":"350","author":"HJ Kim","year":"2015","unstructured":"Kim, H. J. et al. Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science 350, 334\u2013339 (2015).","journal-title":"Science"},{"key":"2910_CR79","doi-asserted-by":"publisher","first-page":"101469","DOI":"10.1016\/j.tranon.2022.101469","volume":"23","author":"K Piersiala","year":"2022","unstructured":"Piersiala, K. et al. Tumour-draining lymph nodes in head and neck cancer are characterized by accumulation of CTLA-4 and PD-1 expressing Treg cells. Transl. Oncol. 23, 101469 (2022).","journal-title":"Transl. Oncol."},{"key":"2910_CR80","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41422-020-0324-7","volume":"30","author":"N Ohkura","year":"2020","unstructured":"Ohkura, N. & Sakaguchi, S. Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases. Cell Res. 30, 465\u2013474 (2020).","journal-title":"Cell Res."},{"key":"2910_CR81","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/imr.12721","volume":"287","author":"N Mitsuiki","year":"2019","unstructured":"Mitsuiki, N., Schwab, C. & Grimbacher, B. What did we learn from CTLA-4 insufficiency on the human immune system? Immunol. Rev. 287, 33\u201349 (2019).","journal-title":"Immunol. Rev."},{"key":"2910_CR82","doi-asserted-by":"publisher","first-page":"753","DOI":"10.4049\/jimmunol.2300154","volume":"213","author":"N Diamantopoulos","year":"2024","unstructured":"Diamantopoulos, N. et al. ICOS-expressing regulatory T cells influence the composition of antitumor CTL populations. J. Immunol. 213, 753\u2013762 (2024).","journal-title":"J. Immunol."},{"key":"2910_CR83","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1111\/cas.16247","volume":"115","author":"F Yan","year":"2024","unstructured":"Yan, F. et al. Prognostic and therapeutic potential of imbalance between PD-1+CD8 and ICOS+Treg cells in advanced HBV-HCC. Cancer Sci. 115, 2553\u20132564 (2024).","journal-title":"Cancer Sci."},{"key":"2910_CR84","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.3389\/fimmu.2020.02104","volume":"11","author":"DY Li","year":"2020","unstructured":"Li, D. Y. & Xiong, X. Z. ICOS(+) Tregs: a functional subset of Tregs in immune diseases. Front. Immunol. 11, 2104 (2020).","journal-title":"Front. Immunol."},{"key":"2910_CR85","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1111\/jcmm.15137","volume":"24","author":"X Jin","year":"2020","unstructured":"Jin, X. et al. Use of Tregs as a cell-based therapy via CD39 for benign prostate hyperplasia with inflammation. J. Cell. Mol. Med. 24, 5082\u20135096 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"2910_CR86","doi-asserted-by":"publisher","first-page":"602605","DOI":"10.3389\/fimmu.2020.602605","volume":"11","author":"C Chen","year":"2020","unstructured":"Chen, C. et al. CD39(+) regulatory T cells attenuate lipopolysaccharide-induced acute lung injury via autophagy and the ERK\/FOS pathway. Front. Immunol. 11, 602605 (2020).","journal-title":"Front. Immunol."},{"key":"2910_CR87","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/bs.pmbts.2019.03.010","volume":"164","author":"J He","year":"2019","unstructured":"He, J. et al. TNFR2-expressing CD4(+)Foxp3(+) regulatory T cells in cancer immunology and immunotherapy. Prog. Mol. Biol. Transl. Sci. 164, 101\u2013117 (2019).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"2910_CR88","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2217\/imt-2022-0185","volume":"15","author":"SJ Abi-Aad","year":"2023","unstructured":"Abi-Aad, S. J. et al. Simultaneous inhibition of PD-1 and LAG-3: the future of immunotherapy? Immunotherapy 15, 611\u2013618 (2023).","journal-title":"Immunotherapy"},{"key":"2910_CR89","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.4049\/jimmunol.1901250","volume":"204","author":"R Opstelten","year":"2020","unstructured":"Opstelten, R. et al. GPA33: a marker to identify stable human regulatory T cells. J. Immunol. 204, 3139\u20133148 (2020).","journal-title":"J. Immunol."},{"key":"2910_CR90","doi-asserted-by":"publisher","first-page":"152749","DOI":"10.1016\/j.imbio.2023.152749","volume":"228","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y. et al. Alterations in Helios+ T cell subsets in peripheral blood of early-stage lung adenocarcinoma patients: implications for early diagnosis. Immunobiology 228, 152749 (2023).","journal-title":"Immunobiology"},{"key":"2910_CR91","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/eji.202048744","volume":"51","author":"R Opstelten","year":"2021","unstructured":"Opstelten, R. et al. GPA33 is expressed on multiple human blood cell types and distinguishes CD4(+) central memory T cells with and without effector function. Eur. J. Immunol. 51, 1377\u20131389 (2021).","journal-title":"Eur. J. Immunol."},{"key":"2910_CR92","doi-asserted-by":"publisher","first-page":"881166","DOI":"10.3389\/fimmu.2022.881166","volume":"13","author":"M Mensink","year":"2022","unstructured":"Mensink, M. et al. TNFR2 costimulation differentially impacts regulatory and conventional CD4(+) T-cell metabolism. Front. Immunol. 13, 881166 (2022).","journal-title":"Front. Immunol."},{"key":"2910_CR93","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1084\/jem.147.4.1116","volume":"147","author":"H Cantor","year":"1978","unstructured":"Cantor, H. et al. Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice. J. Exp. Med. 147, 1116\u20131125 (1978).","journal-title":"J. Exp. Med."},{"key":"2910_CR94","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1126\/science.256.5060.1213","volume":"256","author":"H Jiang","year":"1992","unstructured":"Jiang, H., Zhang, S. I. & Pernis, B. Role of CD8+T cells in murine experimental allergic encephalomyelitis. Science 256, 1213\u20131215 (1992).","journal-title":"Science"},{"key":"2910_CR95","doi-asserted-by":"publisher","first-page":"eabi9591","DOI":"10.1126\/science.abi9591","volume":"376","author":"J Li","year":"2022","unstructured":"Li, J. et al. KIR(+)CD8(+) T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science 376, eabi9591 (2022).","journal-title":"Science"},{"key":"2910_CR96","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fimmu.2015.00171","volume":"6","author":"G Churlaud","year":"2015","unstructured":"Churlaud, G. et al. Human and mouse CD8+CD25+FOXP3+ regulatory T cells at steady state and during interleukin-2 therapy. Front. Immunol. 6, 171 (2015).","journal-title":"Front. Immunol."},{"key":"2910_CR97","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1182\/blood-2011-12-396119","volume":"119","author":"RJ Robb","year":"2012","unstructured":"Robb, R. J. et al. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation. Blood 119, 5898\u20135908 (2012).","journal-title":"Blood"},{"key":"2910_CR98","doi-asserted-by":"publisher","first-page":"eabd3774","DOI":"10.1126\/sciimmunol.abd3774","volume":"6","author":"T Joeris","year":"2021","unstructured":"Joeris, T. et al. Intestinal cDC1 drive cross-tolerance to epithelial-derived antigen via induction of FoxP3+CD Tregs. Sci. Immunol. 6, eabd3774 (2021).","journal-title":"Sci. Immunol."},{"key":"2910_CR99","doi-asserted-by":"crossref","unstructured":"Vuttaradhi, V. K. et al. CD8+ regulatory T cells. Annu. Rev. Immunol. 44, 21\u201340 (2026).","DOI":"10.1146\/annurev-immunol-083024-030412"},{"key":"2910_CR100","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature09370","volume":"467","author":"HJ Kim","year":"2010","unstructured":"Kim, H. J. et al. Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance. Nature 467, 328\u2013332 (2010).","journal-title":"Nature"},{"key":"2910_CR101","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1073\/pnas.1018974108","volume":"108","author":"HJ Kim","year":"2011","unstructured":"Kim, H. J. et al. CD8+T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice. Proc. Natl. Acad. Sci. USA. 108, 2010\u20132015 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR102","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41586-019-1467-x","volume":"572","author":"N Saligrama","year":"2019","unstructured":"Saligrama, N. et al. Opposing T cell responses in experimental autoimmune encephalomyelitis. Nature 572, 481\u2013487 (2019).","journal-title":"Nature"},{"key":"2910_CR103","doi-asserted-by":"publisher","first-page":"eadm7697","DOI":"10.1126\/scitranslmed.adm7697","volume":"17","author":"J Li","year":"2025","unstructured":"Li, J. et al. Regulatory KIR(+)CD8(+) T cells are elevated during human pregnancy. Sci. Transl. Med. 17, eadm7697 (2025).","journal-title":"Sci. Transl. Med."},{"key":"2910_CR104","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41590-024-02062-x","volume":"26","author":"X Chen","year":"2025","unstructured":"Chen, X. et al. Differential roles of human CD4(+) and CD8(+) regulatory T cells in controlling self-reactive immune responses. Nat. Immunol. 26, 230\u2013239 (2025).","journal-title":"Nat. Immunol."},{"key":"2910_CR105","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40257-023-00774-8","volume":"24","author":"D Niebel","year":"2023","unstructured":"Niebel, D. et al. Cutaneous lupus erythematosus: an update on pathogenesis and future therapeutic directions. Am. J. Clin. Dermatol. 24, 521\u2013540 (2023).","journal-title":"Am. J. Clin. Dermatol."},{"key":"2910_CR106","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/nep.12809","volume":"22","author":"CC Lim","year":"2017","unstructured":"Lim, C. C. et al. Severe infections in patients with lupus nephritis treated with immunosuppressants: a retrospective cohort study. Nephrology 22, 478\u2013484 (2017).","journal-title":"Nephrology"},{"key":"2910_CR107","first-page":"Cd007606","volume":"4","author":"C Fairfield","year":"2018","unstructured":"Fairfield, C. et al. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients. Cochrane Database Syst. Rev. 4, Cd007606 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2910_CR108","doi-asserted-by":"publisher","first-page":"eadr6049","DOI":"10.1126\/scitranslmed.adr6049","volume":"17","author":"N Mikami","year":"2025","unstructured":"Mikami, N. et al. Generating functionally stable and antigen-specific T(reg) cells from effector T cells for cell therapy of inflammatory diseases. Sci. Transl. Med. 17, eadr6049 (2025).","journal-title":"Sci. Transl. Med."},{"key":"2910_CR109","doi-asserted-by":"publisher","first-page":"eadq9913","DOI":"10.1126\/scitranslmed.adq9913","volume":"17","author":"M Mukai","year":"2025","unstructured":"Mukai, M. et al. Conversion of pathogenic T cells into functionally stabilized T(reg) cells for antigen-specific immunosuppression in pemphigus vulgaris. Sci. Transl. Med. 17, eadq9913 (2025).","journal-title":"Sci. Transl. Med."},{"key":"2910_CR110","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.immuni.2007.11.021","volume":"28","author":"CW Lio","year":"2008","unstructured":"Lio, C. W. & Hsieh, C. S. A two-step process for thymic regulatory T cell development. Immunity 28, 100\u2013111 (2008).","journal-title":"Immunity"},{"key":"2910_CR111","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nri3667","volume":"14","author":"L Klein","year":"2014","unstructured":"Klein, L., Kyewski, B., Allen, P. M. & Hogquist, K. A. Positive and negative selection of the T cell repertoire: what thymocytes see (and don\u2019t see). Nat. Rev. Immunol. 14, 377\u2013391 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"2910_CR112","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ni1444","volume":"8","author":"K Aschenbrenner","year":"2007","unstructured":"Aschenbrenner, K. et al. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat. Immunol. 8, 351\u2013358 (2007).","journal-title":"Nat. Immunol."},{"key":"2910_CR113","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.immuni.2016.01.025","volume":"44","author":"DS Leventhal","year":"2016","unstructured":"Leventhal, D. S. et al. Dendritic cells coordinate the development and homeostasis of organ-specific regulatory T cells. Immunity 44, 847\u2013859 (2016).","journal-title":"Immunity"},{"key":"2910_CR114","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.immuni.2014.08.007","volume":"41","author":"JSA Perry","year":"2014","unstructured":"Perry, J. S. A. et al. Distinct contributions of Aire and antigen-presenting-cell subsets to the generation of self-tolerance in the thymus. Immunity 41, 414\u2013426 (2014).","journal-title":"Immunity"},{"key":"2910_CR115","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nri.2016.26","volume":"16","author":"MO Li","year":"2016","unstructured":"Li, M. O. & Rudensky, A. Y. T cell receptor signalling in the control of regulatory T cell differentiation and function. Nat. Rev. Immunol. 16, 220\u2013233 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"2910_CR116","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1371\/journal.pbio.1000051","volume":"7","author":"MJ Barnes","year":"2009","unstructured":"Barnes, M. J. et al. Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol. 7, e51 (2009).","journal-title":"PLoS Biol."},{"key":"2910_CR117","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/eji.200838734","volume":"39","author":"BD Medoff","year":"2009","unstructured":"Medoff, B. D. et al. Differential requirement for CARMA1 in agonist-selected T-cell development. Eur. J. Immunol. 39, 78\u201384 (2009).","journal-title":"Eur. J. Immunol."},{"key":"2910_CR118","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/ni1549","volume":"9","author":"Y Tone","year":"2008","unstructured":"Tone, Y. et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9, 194\u2013202 (2008).","journal-title":"Nat. Immunol."},{"key":"2910_CR119","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","volume":"30","author":"SZ Josefowicz","year":"2012","unstructured":"Josefowicz, S. Z., Lu, L. F. & Rudensky, A. Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531\u2013564 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"2910_CR120","doi-asserted-by":"publisher","first-page":"e20220386","DOI":"10.1084\/jem.20220386","volume":"220","author":"A Tanaka","year":"2023","unstructured":"Tanaka, A. et al. Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease. J. Exp. Med. 220, e20220386 (2023).","journal-title":"J. Exp. Med."},{"key":"2910_CR121","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1073\/pnas.0800928105","volume":"105","author":"S Sauer","year":"2008","unstructured":"Sauer, S. et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA. 105, 7797\u20137802 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20070-x","volume":"11","author":"M Watanabe","year":"2020","unstructured":"Watanabe, M., Lu, Y., Breen, M. & Hodes, R. J. B7-CD28 co-stimulation modulates central tolerance via thymic clonal deletion and Treg generation through distinct mechanisms. Nat. Commun. 11, 6264 (2020).","journal-title":"Nat. Commun."},{"key":"2910_CR123","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ni1160","volume":"6","author":"X Tai","year":"2005","unstructured":"Tai, X., Cowan, M., Feigenbaum, L. & Singer, A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6, 152\u2013162 (2005).","journal-title":"Nat. Immunol."},{"key":"2910_CR124","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jaut.2014.11.002","volume":"56","author":"I Caramalho","year":"2015","unstructured":"Caramalho, I. et al. Human regulatory T-cell development is dictated by Interleukin-2 and -15 expressed in a non-overlapping pattern in the thymus. J. Autoimmun. 56, 98\u2013110 (2015).","journal-title":"J. Autoimmun."},{"key":"2910_CR125","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/cei\/uxac105","volume":"211","author":"F Harris","year":"2023","unstructured":"Harris, F., Berdugo, Y. A. & Tree, T. IL-2-based approaches to Treg enhancement. Clin. Exp. Immunol. 211, 149\u2013163 (2023).","journal-title":"Clin. Exp. Immunol."},{"key":"2910_CR126","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/cmi.2018.8","volume":"16","author":"P Kumar","year":"2019","unstructured":"Kumar, P. et al. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation. Cell. Mol. Immunol. 16, 138\u2013153 (2019).","journal-title":"Cell. Mol. Immunol."},{"key":"2910_CR127","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s13238-017-0425-3","volume":"9","author":"C Apert","year":"2018","unstructured":"Apert, C., Romagnoli, P. & van Meerwijk, J. P. M. IL-2 and IL-15 dependent thymic development of Foxp3-expressing regulatory T lymphocytes. Protein Cell 9, 322\u2013332 (2018).","journal-title":"Protein Cell"},{"key":"2910_CR128","doi-asserted-by":"publisher","first-page":"965303","DOI":"10.3389\/fimmu.2022.965303","volume":"13","author":"C Apert","year":"2022","unstructured":"Apert, C. et al. IL-2 and IL-15 drive intrathymic development of distinct periphery-seeding CD4(+)Foxp3(+) regulatory T lymphocytes. Front. Immunol. 13, 965303 (2022).","journal-title":"Front. Immunol."},{"key":"2910_CR129","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/intimm\/dxu079","volume":"27","author":"O Yoshie","year":"2015","unstructured":"Yoshie, O. & Matsushima, K. CCR4 and its ligands: from bench to bedside. Int. Immunol. 27, 11\u201320 (2015).","journal-title":"Int. Immunol."},{"key":"2910_CR130","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/ni.3150","volume":"16","author":"N Thiault","year":"2015","unstructured":"Thiault, N. et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat. Immunol. 16, 628\u2013634 (2015).","journal-title":"Nat. Immunol."},{"key":"2910_CR131","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.celrep.2016.01.003","volume":"14","author":"JE Cowan","year":"2016","unstructured":"Cowan, J. E., McCarthy, N. I. & Anderson, G. CCR7 controls thymus recirculation, but not production and emigration, of Foxp3(+) T cells. Cell Rep. 14, 1041\u20131048 (2016).","journal-title":"Cell Rep."},{"key":"2910_CR132","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41423-019-0352-8","volume":"18","author":"E Nikolouli","year":"2021","unstructured":"Nikolouli, E. et al. Recirculating IL-1R2(+) Tregs fine-tune intrathymic Treg development under inflammatory conditions. Cell. Mol. Immunol. 18, 182\u2013193 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"2910_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2012.11.006","volume":"32","author":"VA Peters","year":"2013","unstructured":"Peters, V. A., Joesting, J. J. & Freund, G. G. IL-1 receptor 2 (IL-1R2) and its role in immune regulation. Brain Behav. Immun. 32, 1\u20138 (2013).","journal-title":"Brain Behav. Immun."},{"key":"2910_CR134","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2172-3-14","volume":"3","author":"A Wesa","year":"2002","unstructured":"Wesa, A. & Galy, A. Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand. BMC Immunol. 3, 14 (2002).","journal-title":"BMC Immunol."},{"key":"2910_CR135","doi-asserted-by":"publisher","first-page":"18460","DOI":"10.1073\/pnas.0809850105","volume":"105","author":"T Korn","year":"2008","unstructured":"Korn, T. et al. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA. 105, 18460\u201318465 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR136","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.immuni.2025.01.006","volume":"58","author":"AL Lemarquis","year":"2025","unstructured":"Lemarquis, A. L. et al. Recirculating regulatory T cells mediate thymic regeneration through amphiregulin following damage. Immunity 58, 397\u2013411.e396 (2025).","journal-title":"Immunity"},{"key":"2910_CR137","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/ni.3004","volume":"15","author":"AG Levine","year":"2014","unstructured":"Levine, A. G., Arvey, A., Jin, W. & Rudensky, A. Y. Continuous requirement for the TCR in regulatory T cell function. Nat. Immunol. 15, 1070\u20131078 (2014).","journal-title":"Nat. Immunol."},{"key":"2910_CR138","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature10434","volume":"478","author":"SK Lathrop","year":"2011","unstructured":"Lathrop, S. K. et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 478, 250\u2013254 (2011).","journal-title":"Nature"},{"key":"2910_CR139","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/ni1318","volume":"7","author":"CS Hsieh","year":"2006","unstructured":"Hsieh, C. S. et al. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 7, 401\u2013410 (2006).","journal-title":"Nat. Immunol."},{"key":"2910_CR140","doi-asserted-by":"publisher","first-page":"ra61","DOI":"10.1126\/scisignal.aad0612","volume":"9","author":"A Yeste","year":"2016","unstructured":"Yeste, A. et al. Tolerogenic nanoparticles inhibit T cell\u2013mediated autoimmunity through SOCS2. Sci. Signal. 9, ra61\u2013ra61 (2016).","journal-title":"Sci. Signal."},{"key":"2910_CR141","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1126\/science.aay3638","volume":"371","author":"C Krienke","year":"2021","unstructured":"Krienke, C. et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science 371, 145\u2013153 (2021).","journal-title":"Science"},{"key":"2910_CR142","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/ACI.0b013e32833fd5eb","volume":"10","author":"AM Scurlock","year":"2010","unstructured":"Scurlock, A. M. & Jones, S. M. An update on immunotherapy for food allergy. Curr. Opin. Allergy Clin. Immunol. 10, 587\u2013593 (2010).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"2910_CR143","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.4049\/jimmunol.1003880","volume":"187","author":"SA Long","year":"2011","unstructured":"Long, S. A. et al. Low-dose antigen promotes induction of FOXP3 in human CD4+T cells. J. Immunol. 187, 3511\u20133520 (2011).","journal-title":"J. Immunol."},{"key":"2910_CR144","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41590-019-0351-z","volume":"20","author":"N Whibley","year":"2019","unstructured":"Whibley, N., Tucci, A. & Powrie, F. Regulatory T cell adaptation in the intestine and skin. Nat. Immunol. 20, 386\u2013396 (2019).","journal-title":"Nat. Immunol."},{"key":"2910_CR145","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.aac5560","volume":"351","author":"KS Kim","year":"2016","unstructured":"Kim, K. S. et al. Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine. Science 351, 858\u2013863 (2016).","journal-title":"Science"},{"key":"2910_CR146","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jaci.2013.12.1037","volume":"133","author":"A Syed","year":"2014","unstructured":"Syed, A. et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J. Allergy Clin. Immunol. 133, 500\u2013510 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2910_CR147","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jaci.2013.11.007","volume":"133","author":"BP Vickery","year":"2014","unstructured":"Vickery, B. P. et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J. Allergy Clin. Immunol. 133, 468\u2013475 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2910_CR148","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41385-020-00358-3","volume":"14","author":"Y Takasato","year":"2021","unstructured":"Takasato, Y. et al. Orally desensitized mast cells form a regulatory network with Treg cells for the control of food allergy. Mucosal Immunol. 14, 640\u2013651 (2021).","journal-title":"Mucosal Immunol."},{"key":"2910_CR149","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/all.15512","volume":"78","author":"D Lozano-Ojalvo","year":"2023","unstructured":"Lozano-Ojalvo, D. et al. Allergen recognition by specific effector Th2 cells enables IL-2-dependent activation of regulatory T-cell responses in humans. Allergy 78, 697\u2013713 (2023).","journal-title":"Allergy"},{"key":"2910_CR150","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1084\/jem.20041982","volume":"201","author":"R Setoguchi","year":"2005","unstructured":"Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723\u2013735 (2005).","journal-title":"J. Exp. Med."},{"key":"2910_CR151","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","volume":"38","author":"W Liao","year":"2013","unstructured":"Liao, W., Lin, J. X. & Leonard, W. J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38, 13\u201325 (2013).","journal-title":"Immunity"},{"key":"2910_CR152","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1126\/science.7973659","volume":"266","author":"T Miyazaki","year":"1994","unstructured":"Miyazaki, T. et al. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266, 1045\u20131047 (1994).","journal-title":"Science"},{"key":"2910_CR153","doi-asserted-by":"publisher","first-page":"5605","DOI":"10.1002\/j.1460-2075.1994.tb06898.x","volume":"13","author":"C Beadling","year":"1994","unstructured":"Beadling, C. et al. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. EMBO J. 13, 5605\u20135615 (1994).","journal-title":"EMBO J."},{"key":"2910_CR154","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","volume":"36","author":"SH Ross","year":"2018","unstructured":"Ross, S. H. & Cantrell, D. A. Signaling and function of interleukin-2 in T lymphocytes. Annu. Rev. Immunol. 36, 411\u2013433 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"2910_CR155","doi-asserted-by":"publisher","first-page":"112996","DOI":"10.1016\/j.celrep.2023.112996","volume":"42","author":"H Sun","year":"2023","unstructured":"Sun, H. et al. IL-2 can signal via chemokine receptors to promote regulatory T cells\u2019 suppressive function. Cell Rep. 42, 112996 (2023).","journal-title":"Cell Rep."},{"key":"2910_CR156","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/eji.200939613","volume":"40","author":"YY Setiady","year":"2010","unstructured":"Setiady, Y. Y., Coccia, J. A. & Park, P. U. In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes. Eur. J. Immunol. 40, 780\u2013786 (2010).","journal-title":"Eur. J. Immunol."},{"key":"2910_CR157","doi-asserted-by":"publisher","first-page":"eaat1482","DOI":"10.1126\/sciimmunol.aat1482","volume":"3","author":"AK Abbas","year":"2018","unstructured":"Abbas, A. K. et al. Revisiting IL-2: biology and therapeutic prospects. Sci. Immunol. 3, eaat1482 (2018).","journal-title":"Sci. Immunol."},{"key":"2910_CR158","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.it.2015.10.003","volume":"36","author":"N Arenas-Ramirez","year":"2015","unstructured":"Arenas-Ramirez, N., Woytschak, J. & Boyman, O. Interleukin-2: biology, design and application. Trends Immunol. 36, 763\u2013777 (2015).","journal-title":"Trends Immunol."},{"key":"2910_CR159","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41591-018-0070-2","volume":"24","author":"E Trotta","year":"2018","unstructured":"Trotta, E. et al. A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism. Nat. Med. 24, 1005\u20131014 (2018).","journal-title":"Nat. Med."},{"key":"2910_CR160","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.2337\/db14-1322","volume":"64","author":"A Yu","year":"2015","unstructured":"Yu, A. et al. Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. Diabetes 64, 2172\u20132183 (2015).","journal-title":"Diabetes"},{"key":"2910_CR161","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.immuni.2008.03.016","volume":"28","author":"Q Tang","year":"2008","unstructured":"Tang, Q. et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28, 687\u2013697 (2008).","journal-title":"Immunity"},{"key":"2910_CR162","first-page":"2009","volume":"50","author":"MW Konrad","year":"1990","unstructured":"Konrad, M. W. et al. Pharmacokinetics of recombinant interleukin 2 in humans. Cancer Res. 50, 2009\u20132017 (1990).","journal-title":"Cancer Res."},{"key":"2910_CR163","doi-asserted-by":"publisher","first-page":"e003155","DOI":"10.1136\/jitc-2021-003155","volume":"10","author":"R Merchant","year":"2022","unstructured":"Merchant, R. et al. Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate. J. Immunother. Cancer 10, e003155 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"2910_CR164","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.2337\/db12-0049","volume":"61","author":"SA Long","year":"2012","unstructured":"Long, S. A. et al. Rapamycin\/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs \u03b2-cell function. Diabetes 61, 2340\u20132348 (2012).","journal-title":"Diabetes"},{"key":"2910_CR165","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2015.04.015","volume":"42","author":"JB Spangler","year":"2015","unstructured":"Spangler, J. B. et al. Antibodies to interleukin-2 elicit selective T cell subset potentiation through distinct conformational mechanisms. Immunity 42, 815\u2013825 (2015).","journal-title":"Immunity"},{"key":"2910_CR166","doi-asserted-by":"publisher","first-page":"13508","DOI":"10.1073\/pnas.1903165116","volume":"116","author":"N Pilat","year":"2019","unstructured":"Pilat, N. et al. Treg-mediated prolonged survival of skin allografts without immunosuppression. Proc. Natl. Acad. Sci. USA. 116, 13508\u201313516 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR167","doi-asserted-by":"publisher","first-page":"eaba5264","DOI":"10.1126\/sciimmunol.aba5264","volume":"5","author":"L Khoryati","year":"2020","unstructured":"Khoryati, L. et al. An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice. Sci. Immunol. 5, eaba5264 (2020).","journal-title":"Sci. Immunol."},{"key":"2910_CR168","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1182\/blood.2020006345","volume":"137","author":"Q Song","year":"2021","unstructured":"Song, Q. et al. Tolerogenic anti-IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity. Blood 137, 2243\u20132255 (2021).","journal-title":"Blood"},{"key":"2910_CR169","doi-asserted-by":"publisher","first-page":"111478","DOI":"10.1016\/j.celrep.2022.111478","volume":"41","author":"D VanDyke","year":"2022","unstructured":"VanDyke, D. et al. Engineered human cytokine\/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection. Cell Rep. 41, 111478 (2022).","journal-title":"Cell Rep."},{"key":"2910_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.10.017","volume":"95","author":"LB Peterson","year":"2018","unstructured":"Peterson, L. B. et al. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease. J. Autoimmun. 95, 1\u201314 (2018).","journal-title":"J. Autoimmun."},{"key":"2910_CR171","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3389\/fimmu.2020.01106","volume":"11","author":"A Ghelani","year":"2020","unstructured":"Ghelani, A. et al. Defining the threshold IL-2 signal required for induction of selective Treg cell responses using engineered IL-2 muteins. Front. Immunol. 11, 1106 (2020).","journal-title":"Front. Immunol."},{"key":"2910_CR172","doi-asserted-by":"publisher","first-page":"114938","DOI":"10.1016\/j.celrep.2024.114938","volume":"43","author":"BL Jamison","year":"2024","unstructured":"Jamison, B. L. et al. An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy. Cell Rep. 43, 114938 (2024).","journal-title":"Cell Rep."},{"key":"2910_CR173","doi-asserted-by":"publisher","first-page":"e173107","DOI":"10.1172\/JCI173107","volume":"134","author":"O Efe","year":"2024","unstructured":"Efe, O. et al. A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models. J. Clin. Invest. 134, e173107 (2024).","journal-title":"J. Clin. Invest."},{"key":"2910_CR174","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","volume":"24","author":"MO Li","year":"2006","unstructured":"Li, M. O. et al. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24, 99\u2013146 (2006).","journal-title":"Annu. Rev. Immunol."},{"key":"2910_CR175","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","volume":"20","author":"J Wang","year":"2023","unstructured":"Wang, J., Zhao, X. & Wan, Y. Y. Intricacies of TGF-\u03b2 signaling in Treg and Th17 cell biology. Cell. Mol. Immunol. 20, 1002\u20131022 (2023).","journal-title":"Cell. Mol. Immunol."},{"key":"2910_CR176","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1084\/jem.20042276","volume":"201","author":"JC Marie","year":"2005","unstructured":"Marie, J. C., Letterio, J. J., Gavin, M. & Rudensky, A. Y. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201, 1061\u20131067 (2005).","journal-title":"J. Exp. Med."},{"key":"2910_CR177","doi-asserted-by":"publisher","first-page":"e133977","DOI":"10.1172\/jci.insight.133977","volume":"5","author":"N Tang","year":"2020","unstructured":"Tang, N. et al. TGF-\u03b2 inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors. JCI Insight 5, e133977 (2020).","journal-title":"JCI Insight"},{"key":"2910_CR178","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.it.2016.08.012","volume":"37","author":"M Kanamori","year":"2016","unstructured":"Kanamori, M. et al. Induced regulatory T cells: their development, stability, and applications. Trends Immunol. 37, 803\u2013811 (2016).","journal-title":"Trends Immunol."},{"key":"2910_CR179","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature08750","volume":"463","author":"Y Zheng","year":"2010","unstructured":"Zheng, Y. et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808\u2013812 (2010).","journal-title":"Nature"},{"key":"2910_CR180","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.immuni.2010.04.012","volume":"32","author":"W Ouyang","year":"2010","unstructured":"Ouyang, W., Beckett, O., Ma, Q. & Li, M. O. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 32, 642\u2013653 (2010).","journal-title":"Immunity"},{"key":"2910_CR181","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ni.1997","volume":"12","author":"JE Konkel","year":"2011","unstructured":"Konkel, J. E. et al. Control of the development of CD8\u03b1\u03b1+ intestinal intraepithelial lymphocytes by TGF-\u03b2. Nat. Immunol. 12, 312\u2013319 (2011).","journal-title":"Nat. Immunol."},{"key":"2910_CR182","doi-asserted-by":"publisher","first-page":"102709","DOI":"10.1016\/j.redox.2023.102709","volume":"62","author":"Y Fang","year":"2023","unstructured":"Fang, Y. et al. Mitochondrial fusion induced by transforming growth factor-\u03b21 serves as a switch that governs the metabolic reprogramming during differentiation of regulatory T cells. Redox Biol. 62, 102709 (2023).","journal-title":"Redox Biol."},{"key":"2910_CR183","doi-asserted-by":"publisher","first-page":"172721","DOI":"10.1016\/j.ejphar.2019.172721","volume":"864","author":"I Koprivica","year":"2019","unstructured":"Koprivica, I. et al. Orally delivered all-trans-retinoic acid- and transforming growth factor-\u03b2-loaded microparticles ameliorate type 1 diabetes in mice. Eur. J. Pharmacol. 864, 172721 (2019).","journal-title":"Eur. J. Pharmacol."},{"key":"2910_CR184","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1182\/blood-2007-06-096438","volume":"111","author":"KM Elias","year":"2008","unstructured":"Elias, K. M. et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3\/Stat-5 independent signaling pathway. Blood 111, 1013\u20131020 (2008).","journal-title":"Blood"},{"key":"2910_CR185","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1145697","volume":"317","author":"D Mucida","year":"2007","unstructured":"Mucida, D. et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256\u2013260 (2007).","journal-title":"Science"},{"key":"2910_CR186","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri.2016.112","volume":"16","author":"W Chen","year":"2016","unstructured":"Chen, W. & Ten Dijke, P. Immunoregulation by members of the TGF\u03b2 superfamily. Nat. Rev. Immunol. 16, 723\u2013740 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"2910_CR187","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-024-07098-5","volume":"627","author":"AG York","year":"2024","unstructured":"York, A. G. et al. IL-10 constrains sphingolipid metabolism to limit inflammation. Nature 627, 628\u2013635 (2024).","journal-title":"Nature"},{"key":"2910_CR188","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","volume":"34","author":"A Chaudhry","year":"2011","unstructured":"Chaudhry, A. et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34, 566\u2013578 (2011).","journal-title":"Immunity"},{"key":"2910_CR189","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.immuni.2014.03.011","volume":"40","author":"DS Shouval","year":"2014","unstructured":"Shouval, D. S. et al. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity 40, 706\u2013719 (2014).","journal-title":"Immunity"},{"key":"2910_CR190","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.992","volume":"12","author":"J Song","year":"2022","unstructured":"Song, J. et al. MiR-192-5p\/RB1\/NF-\u03baBp65 signaling axis promotes IL-10 secretion during gastric cancer EMT to induce Treg cell differentiation in the tumour microenvironment. Clin. Transl. Med. 12, e992 (2022).","journal-title":"Clin. Transl. Med."},{"key":"2910_CR191","doi-asserted-by":"publisher","first-page":"104603","DOI":"10.1016\/j.ebiom.2023.104603","volume":"92","author":"T Laragione","year":"2023","unstructured":"Laragione, T. et al. Magnesium increases numbers of Foxp3+ Treg cells and reduces arthritis severity and joint damage in an IL-10-dependent manner mediated by the intestinal microbiome. EBioMedicine 92, 104603 (2023).","journal-title":"EBioMedicine"},{"key":"2910_CR192","doi-asserted-by":"publisher","first-page":"e54096","DOI":"10.15252\/embr.202154096","volume":"23","author":"UF Prodjinotho","year":"2022","unstructured":"Prodjinotho, U. F. et al. Helminthic dehydrogenase drives PGE(2) and IL-10 production in monocytes to potentiate Treg induction. EMBO Rep. 23, e54096 (2022).","journal-title":"EMBO Rep."},{"key":"2910_CR193","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.4049\/jimmunol.1402898","volume":"195","author":"P Hsu","year":"2015","unstructured":"Hsu, P. et al. IL-10 potentiates differentiation of human induced regulatory T cells via STAT3 and Foxo1. J. Immunol. 195, 3665\u20133674 (2015).","journal-title":"J. Immunol."},{"key":"2910_CR194","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nature11581","volume":"491","author":"W Ouyang","year":"2012","unstructured":"Ouyang, W. et al. Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature 491, 554\u2013559 (2012).","journal-title":"Nature"},{"key":"2910_CR195","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50392-z","volume":"15","author":"X Yang","year":"2024","unstructured":"Yang, X. et al. RNF213 promotes Treg cell differentiation by facilitating K63-linked ubiquitination and nuclear translocation of FOXO1. Nat. Commun. 15, 5961 (2024).","journal-title":"Nat. Commun."},{"key":"2910_CR196","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ni.1884","volume":"11","author":"W Ouyang","year":"2010","unstructured":"Ouyang, W. et al. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 11, 618\u2013627 (2010).","journal-title":"Nat. Immunol."},{"key":"2910_CR197","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.immuni.2010.12.002","volume":"33","author":"YM Kerdiles","year":"2010","unstructured":"Kerdiles, Y. M. et al. Foxo transcription factors control regulatory T cell development and function. Immunity 33, 890\u2013904 (2010).","journal-title":"Immunity"},{"key":"2910_CR198","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","volume":"450","author":"LW Collison","year":"2007","unstructured":"Collison, L. W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566\u2013569 (2007).","journal-title":"Nature"},{"key":"2910_CR199","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/ni.2227","volume":"13","author":"LW Collison","year":"2012","unstructured":"Collison, L. W. et al. The composition and signaling of the IL-35 receptor are unconventional. Nat. Immunol. 13, 290\u2013299 (2012).","journal-title":"Nat. Immunol."},{"key":"2910_CR200","doi-asserted-by":"publisher","first-page":"e152511","DOI":"10.1172\/jci.insight.152511","volume":"6","author":"Y Shao","year":"2021","unstructured":"Shao, Y. et al. IL-35 promotes CD4+Foxp3+ Tregs and inhibits atherosclerosis via maintaining CCR5-amplified Treg-suppressive mechanisms. JCI Insight 6, e152511 (2021).","journal-title":"JCI Insight"},{"key":"2910_CR201","doi-asserted-by":"publisher","first-page":"eadd8693","DOI":"10.1126\/sciadv.add8693","volume":"9","author":"KR Rhodes","year":"2023","unstructured":"Rhodes, K. R. et al. Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosis. Sci. Adv. 9, eadd8693 (2023).","journal-title":"Sci. Adv."},{"key":"2910_CR202","doi-asserted-by":"publisher","first-page":"12258","DOI":"10.1073\/pnas.1922600117","volume":"117","author":"N Mikami","year":"2020","unstructured":"Mikami, N. et al. Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation. Proc. Natl. Acad. Sci. USA. 117, 12258\u201312268 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR203","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2012.09.010","volume":"37","author":"N Ohkura","year":"2012","unstructured":"Ohkura, N. et al. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37, 785\u2013799 (2012).","journal-title":"Immunity"},{"key":"2910_CR204","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri3198","volume":"12","author":"H Chi","year":"2012","unstructured":"Chi, H. Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 12, 325\u2013338 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"2910_CR205","doi-asserted-by":"publisher","first-page":"909705","DOI":"10.3389\/fimmu.2022.909705","volume":"13","author":"K Yang","year":"2022","unstructured":"Yang, K. Regulation of Treg cell metabolism and function in non-lymphoid tissues. Front. Immunol. 13, 909705 (2022).","journal-title":"Front. Immunol."},{"key":"2910_CR206","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20110278","volume":"208","author":"LZ Shi","year":"2011","unstructured":"Shi, L. Z. et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367\u20131376 (2011).","journal-title":"J. Exp. Med."},{"key":"2910_CR207","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15677","volume":"8","author":"AAK Layman","year":"2017","unstructured":"Layman, A. A. K. et al. Ndfip1 restricts mTORC1 signalling and glycolysis in regulatory T cells to prevent autoinflammatory disease. Nat. Commun. 8, 15677 (2017).","journal-title":"Nat. Commun."},{"key":"2910_CR208","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1172\/JCI69751","volume":"123","author":"Y Park","year":"2013","unstructured":"Park, Y. et al. TSC1 regulates the balance between effector and regulatory T cells. J. Clin. Invest. 123, 5165\u20135178 (2013).","journal-title":"J. Clin. Invest."},{"key":"2910_CR209","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ni.3076","volume":"16","author":"S Shrestha","year":"2015","unstructured":"Shrestha, S. et al. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat. Immunol. 16, 178\u2013187 (2015).","journal-title":"Nat. Immunol."},{"key":"2910_CR210","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev-immunol-020711-075024","volume":"30","author":"JD Powell","year":"2012","unstructured":"Powell, J. D., Pollizzi, K. N., Heikamp, E. B. & Horton, M. R. Regulation of immune responses by mTOR. Annu. Rev. Immunol. 30, 39\u201368 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"2910_CR211","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1084\/jem.20101156","volume":"207","author":"M Merkenschlager","year":"2010","unstructured":"Merkenschlager, M. & von Boehmer, H. PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors. J. Exp. Med. 207, 1347\u20131350 (2010).","journal-title":"J. Exp. Med."},{"key":"2910_CR212","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.immuni.2010.11.024","volume":"33","author":"C Procaccini","year":"2010","unstructured":"Procaccini, C. et al. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 33, 929\u2013941 (2010).","journal-title":"Immunity"},{"key":"2910_CR213","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1002\/eji.201142317","volume":"42","author":"JH Lee","year":"2012","unstructured":"Lee, J. H., Lydon, J. P. & Kim, C. H. Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability. Eur. J. Immunol. 42, 2683\u20132696 (2012).","journal-title":"Eur. J. Immunol."},{"key":"2910_CR214","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ni.3466","volume":"17","author":"R Newton","year":"2016","unstructured":"Newton, R., Priyadharshini, B. & Turka, L. A. Immunometabolism of regulatory T cells. Nat. Immunol. 17, 618\u2013625 (2016).","journal-title":"Nat. Immunol."},{"key":"2910_CR215","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/ni.3077","volume":"16","author":"A Huynh","year":"2015","unstructured":"Huynh, A. et al. Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nat. Immunol. 16, 188\u2013196 (2015).","journal-title":"Nat. Immunol."},{"key":"2910_CR216","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","volume":"499","author":"H Zeng","year":"2013","unstructured":"Zeng, H. et al. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 499, 485\u2013490 (2013).","journal-title":"Nature"},{"key":"2910_CR217","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc2676","volume":"9","author":"DB Shackelford","year":"2009","unstructured":"Shackelford, D. B. & Shaw, R. J. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat. Rev. Cancer 9, 563\u2013575 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"2910_CR218","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15876","volume":"8","author":"D Wu","year":"2017","unstructured":"Wu, D. et al. Lkb1 maintains T(reg) cell lineage identity. Nat. Commun. 8, 15876 (2017).","journal-title":"Nat. Commun."},{"key":"2910_CR219","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17750-z","volume":"11","author":"LF Campesato","year":"2020","unstructured":"Campesato, L. F. et al. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine. Nat. Commun. 11, 4011 (2020).","journal-title":"Nat. Commun."},{"key":"2910_CR220","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.tips.2017.11.007","volume":"39","author":"JE Cheong","year":"2018","unstructured":"Cheong, J. E. & Sun, L. Targeting the IDO1\/TDO2-KYN-AhR pathway for cancer immunotherapy - challenges and opportunities. Trends Pharmacol. Sci. 39, 307\u2013325 (2018).","journal-title":"Trends Pharmacol. Sci."},{"key":"2910_CR221","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/imm.13638","volume":"169","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. AhR activation promotes Treg cell generation by enhancing Lkb1-mediated fatty acid oxidation via the Skp2\/K63-ubiquitination pathway. Immunology 169, 412\u2013430 (2023).","journal-title":"Immunology"},{"key":"2910_CR222","doi-asserted-by":"publisher","first-page":"12542","DOI":"10.1073\/pnas.1715363114","volume":"114","author":"N He","year":"2017","unstructured":"He, N. et al. Metabolic control of regulatory T cell (Treg) survival and function by Lkb1. Proc. Natl. Acad. Sci. USA. 114, 12542\u201312547 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR223","doi-asserted-by":"publisher","first-page":"e166628","DOI":"10.1172\/JCI166628","volume":"133","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Zfp335 establishes eTreg lineage and neonatal immune tolerance by targeting Hadha-mediated fatty acid oxidation. J. Clin. Invest. 133, e166628 (2023).","journal-title":"J. Clin. Invest."},{"key":"2910_CR224","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1016\/j.celrep.2019.05.020","volume":"27","author":"M Timilshina","year":"2019","unstructured":"Timilshina, M. et al. Activation of mevalonate pathway via LKB1 is essential for stability of T(reg) cells. Cell Rep. 27, 2948\u20132961.e2947 (2019).","journal-title":"Cell Rep."},{"key":"2910_CR225","doi-asserted-by":"publisher","first-page":"e20211314","DOI":"10.1084\/jem.20211314","volume":"219","author":"Y Chen","year":"2022","unstructured":"Chen, Y., Zhang, J., Cui, W. & Silverstein, R. L. CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate. J. Exp. Med. 219, e20211314 (2022).","journal-title":"J. Exp. Med."},{"key":"2910_CR226","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.molmed.2010.07.008","volume":"16","author":"V Leduc","year":"2010","unstructured":"Leduc, V., Jasmin-B\u00e9langer, S. & Poirier, J. APOE and cholesterol homeostasis in Alzheimer\u2019s disease. Trends Mol. Med. 16, 469\u2013477 (2010).","journal-title":"Trends Mol. Med."},{"key":"2910_CR227","doi-asserted-by":"publisher","first-page":"1780865","DOI":"10.3389\/fimmu.2026.1780865","volume":"17","author":"H Chen","year":"2026","unstructured":"Chen, H. et al. Gut microbial metabolites in inflammatory bowel disease: immunological mechanisms regulating Treg\/Th17 balance and therapeutic potential. Front Immunol. 17, 1780865 (2026).","journal-title":"Front Immunol."},{"key":"2910_CR228","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cell.2025.11.022","volume":"189","author":"JA Brown","year":"2026","unstructured":"Brown, J. A. et al. Gut microbiota promotes immune tolerance at the maternal-fetal interface. Cell 189, 196\u2013214.e124 (2026).","journal-title":"Cell"},{"key":"2910_CR229","doi-asserted-by":"publisher","first-page":"2557979","DOI":"10.1080\/19490976.2025.2557979","volume":"17","author":"B Li","year":"2025","unstructured":"Li, B. et al. Tryptophan catabolites from microbiota ameliorate immune-mediated hepatitis through activating aryl hydrocarbon receptor of T cells. Gut Microbes 17, 2557979 (2025).","journal-title":"Gut Microbes"},{"key":"2910_CR230","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-022-01322-3","volume":"15","author":"Y Yan","year":"2022","unstructured":"Yan, Y. et al. Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity. J. Hematol. Oncol. 15, 104 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"2910_CR231","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson, M. J. et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591, 645\u2013651 (2021).","journal-title":"Nature"},{"key":"2910_CR232","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai, S. et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell 40, 201\u2013218.e209 (2022).","journal-title":"Cancer Cell"},{"key":"2910_CR233","doi-asserted-by":"publisher","first-page":"101600","DOI":"10.1016\/j.omtm.2025.101600","volume":"33","author":"K Tuomela","year":"2025","unstructured":"Tuomela, K. et al. Lactic acid improves Treg manufacturing and in vivo function. Mol. Ther. Methods Clin. Dev. 33, 101600 (2025).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2910_CR234","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1002\/eji.200939432","volume":"39","author":"C Koenecke","year":"2009","unstructured":"Koenecke, C. et al. Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD. Eur. J. Immunol. 39, 3091\u20133096 (2009).","journal-title":"Eur. J. Immunol."},{"key":"2910_CR235","doi-asserted-by":"publisher","first-page":"110124","DOI":"10.1016\/j.celrep.2021.110124","volume":"37","author":"J Li","year":"2021","unstructured":"Li, J. et al. Control of Foxp3 induction and maintenance by sequential histone acetylation and DNA demethylation. Cell Rep. 37, 110124 (2021).","journal-title":"Cell Rep."},{"key":"2910_CR236","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00109-010-0642-1","volume":"88","author":"JK Polansky","year":"2010","unstructured":"Polansky, J. K. et al. Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells. J. Mol. Med. 88, 1029\u20131040 (2010).","journal-title":"J. Mol. Med."},{"key":"2910_CR237","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jaut.2017.07.002","volume":"83","author":"M Iizuka-Koga","year":"2017","unstructured":"Iizuka-Koga, M. et al. Induction and maintenance of regulatory T cells by transcription factors and epigenetic modifications. J. Autoimmun. 83, 113\u2013121 (2017).","journal-title":"J. Autoimmun."},{"key":"2910_CR238","doi-asserted-by":"publisher","first-page":"16258","DOI":"10.1073\/pnas.1203870109","volume":"109","author":"M Vaeth","year":"2012","unstructured":"Vaeth, M. et al. Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA. 109, 16258\u201316263 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR239","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s10753-024-02031-4","volume":"47","author":"RD Arroyo-Olarte","year":"2024","unstructured":"Arroyo-Olarte, R. D. et al. Targeted demethylation of FOXP3-TSDR enhances the suppressive capacity of STAT6-deficient inducible T regulatory cells. Inflammation 47, 2159\u20132172 (2024).","journal-title":"Inflammation"},{"key":"2910_CR240","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.immuni.2015.07.017","volume":"43","author":"R Yang","year":"2015","unstructured":"Yang, R. et al. Hydrogen sulfide promotes Tet1- and Tet2-mediated Foxp3 demethylation to drive regulatory T cell differentiation and maintain immune homeostasis. Immunity 43, 251\u2013263 (2015).","journal-title":"Immunity"},{"key":"2910_CR241","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature12750","volume":"502","author":"RM Kohli","year":"2013","unstructured":"Kohli, R. M. & Zhang, Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502, 472\u2013479 (2013).","journal-title":"Nature"},{"key":"2910_CR242","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cell.2013.06.026","volume":"154","author":"SJ Song","year":"2013","unstructured":"Song, S. J. et al. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 154, 311\u2013324 (2013).","journal-title":"Cell"},{"key":"2910_CR243","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1084\/jem.20151438","volume":"213","author":"X Yue","year":"2016","unstructured":"Yue, X. et al. Control of Foxp3 stability through modulation of TET activity. J. Exp. Med. 213, 377\u2013397 (2016).","journal-title":"J. Exp. Med."},{"key":"2910_CR244","doi-asserted-by":"publisher","first-page":"e52716","DOI":"10.15252\/embr.202152716","volume":"22","author":"X Yue","year":"2021","unstructured":"Yue, X. et al. Whole-genome analysis of TET dioxygenase function in regulatory T cells. EMBO Rep. 22, e52716 (2021).","journal-title":"EMBO Rep."},{"key":"2910_CR245","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1016\/j.bbrc.2018.07.021","volume":"503","author":"E Wakamatsu","year":"2018","unstructured":"Wakamatsu, E. et al. Strong TCR stimulation promotes the stabilization of Foxp3 expression in regulatory T cells induced in vitro through increasing the demethylation of Foxp3 CNS2. Biochem. Biophys. Res. Commun. 503, 2597\u20132602 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2910_CR246","doi-asserted-by":"publisher","first-page":"14955","DOI":"10.1074\/jbc.M801123200","volume":"283","author":"H Takaki","year":"2008","unstructured":"Takaki, H. et al. STAT6 Inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J. Biol. Chem. 283, 14955\u201314962 (2008).","journal-title":"J. Biol. Chem."},{"key":"2910_CR247","doi-asserted-by":"publisher","first-page":"e2250128","DOI":"10.1002\/eji.202250128","volume":"53","author":"RD Arroyo-Olarte","year":"2023","unstructured":"Arroyo-Olarte, R. D. et al. STAT6 controls the stability and suppressive function of regulatory T cells. Eur. J. Immunol. 53, e2250128 (2023).","journal-title":"Eur. J. Immunol."},{"key":"2910_CR248","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.4049\/jimmunol.2000537","volume":"205","author":"J Cameron","year":"2020","unstructured":"Cameron, J., Martino, P., Nguyen, L. & Li, X. Cutting edge: CRISPR-based transcriptional regulators reveal transcription-dependent establishment of epigenetic memory of Foxp3 in regulatory T cells. J. Immunol. 205, 2953\u20132958 (2020).","journal-title":"J. Immunol."},{"key":"2910_CR249","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.coi.2010.08.013","volume":"22","author":"Y Xiao","year":"2010","unstructured":"Xiao, Y. et al. Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function. Curr. Opin. Immunol. 22, 583\u2013591 (2010).","journal-title":"Curr. Opin. Immunol."},{"key":"2910_CR250","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrg2485","volume":"10","author":"M Haberland","year":"2009","unstructured":"Haberland, M., Montgomery, R. L. & Olson, E. N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet 10, 32\u201342 (2009).","journal-title":"Nat. Rev. Genet"},{"key":"2910_CR251","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/nm1652","volume":"13","author":"R Tao","year":"2007","unstructured":"Tao, R. et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13, 1299\u20131307 (2007).","journal-title":"Nat. Med."},{"key":"2910_CR252","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1158\/0008-5472.CAN-18-3622","volume":"79","author":"J Castillo","year":"2019","unstructured":"Castillo, J. et al. CBP\/p300 drives the differentiation of regulatory T cells through transcriptional and non-transcriptional mechanisms. Cancer Res. 79, 3916\u20133927 (2019).","journal-title":"Cancer Res."},{"key":"2910_CR253","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.7150\/thno.73223","volume":"12","author":"Q Chen","year":"2022","unstructured":"Chen, Q. et al. Histone acetyltransferases CBP\/p300 in tumorigenesis and CBP\/p300 inhibitors as promising novel anticancer agents. Theranostics 12, 4935\u20134948 (2022).","journal-title":"Theranostics"},{"key":"2910_CR254","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm.3286","volume":"19","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. Inhibition of p300 impairs Foxp3\u207a T regulatory cell function and promotes antitumor immunity. Nat. Med. 19, 1173\u20131177 (2013).","journal-title":"Nat. Med."},{"key":"2910_CR255","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1128\/MCB.00919-14","volume":"34","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Two histone\/protein acetyltransferases, CBP and p300, are indispensable for Foxp3+ T-regulatory cell development and function. Mol. Cell Biol. 34, 3993\u20134007 (2014).","journal-title":"Mol. Cell Biol."},{"key":"2910_CR256","doi-asserted-by":"publisher","first-page":"626172","DOI":"10.3389\/fimmu.2021.626172","volume":"12","author":"Y Dong","year":"2021","unstructured":"Dong, Y., Yang, C. & Pan, F. Post-translational regulations of Foxp3 in Treg cells and their therapeutic applications. Front. Immunol. 12, 626172 (2021).","journal-title":"Front. Immunol."},{"key":"2910_CR257","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.immuni.2010.09.001","volume":"33","author":"L Xu","year":"2010","unstructured":"Xu, L. et al. Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 33, 313\u2013325 (2010).","journal-title":"Immunity"},{"key":"2910_CR258","doi-asserted-by":"publisher","first-page":"2560019","DOI":"10.1080\/19490976.2025.2560019","volume":"17","author":"Z Ma","year":"2025","unstructured":"Ma, Z. et al. Regulatory roles of intestinal CD4(+) T cells in inflammation and their modulation by the intestinal microbiota. Gut Microbes 17, 2560019 (2025).","journal-title":"Gut Microbes"},{"key":"2910_CR259","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451\u2013455 (2013).","journal-title":"Nature"},{"key":"2910_CR260","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446\u2013450 (2013).","journal-title":"Nature"},{"key":"2910_CR261","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569\u2013573 (2013).","journal-title":"Science"},{"key":"2910_CR262","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jare.2025.08.017","volume":"83","author":"L Liu","year":"2026","unstructured":"Liu, L. et al. Microbiome-metabolome generated bile acids gatekeep infliximab efficacy in Crohn\u2019s disease by licensing M1 suppression and Treg dominance. J. Adv. Res. 83, 789\u2013806 (2026).","journal-title":"J. Adv. Res."},{"key":"2910_CR263","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang, S. et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature 576, 143\u2013148 (2019).","journal-title":"Nature"},{"key":"2910_CR264","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.chom.2021.07.013","volume":"29","author":"W Li","year":"2021","unstructured":"Li, W. et al. A bacterial bile acid metabolite modulates T(reg) activity through the nuclear hormone receptor NR4A1. Cell Host Microbe 29, 1366\u20131377.e1369 (2021).","journal-title":"Cell Host Microbe"},{"key":"2910_CR265","doi-asserted-by":"publisher","first-page":"1519671","DOI":"10.3389\/fimmu.2024.1519671","volume":"15","author":"Y Kong","year":"2024","unstructured":"Kong, Y. et al. CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity. Front. Immunol. 15, 1519671 (2024).","journal-title":"Front. Immunol."},{"key":"2910_CR266","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner, R. C. & Sterner, R. M. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021).","journal-title":"Blood Cancer J."},{"key":"2910_CR267","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.tibtech.2019.12.009","volume":"38","author":"E Fritsche","year":"2020","unstructured":"Fritsche, E., Volk, H. D., Reinke, P. & Abou-El-Enein, M. Toward an optimized process for clinical manufacturing of CAR-Treg cell therapy. Trends Biotechnol. 38, 1099\u20131112 (2020).","journal-title":"Trends Biotechnol."},{"key":"2910_CR268","doi-asserted-by":"publisher","first-page":"114994","DOI":"10.1016\/j.celrep.2024.114994","volume":"43","author":"JM Barra","year":"2024","unstructured":"Barra, J. M. et al. Combinatorial genetic engineering strategy for immune protection of stem cell-derived beta cells by chimeric antigen receptor regulatory T cells. Cell Rep. 43, 114994 (2024).","journal-title":"Cell Rep."},{"key":"2910_CR269","doi-asserted-by":"publisher","first-page":"686439","DOI":"10.3389\/fimmu.2021.686439","volume":"12","author":"YD Muller","year":"2021","unstructured":"Muller, Y. D. et al. Precision engineering of an Anti-HLA-A2 chimeric antigen receptor in regulatory T cells for transplant immune tolerance. Front. Immunol. 12, 686439 (2021).","journal-title":"Front. Immunol."},{"key":"2910_CR270","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.it.2023.11.005","volume":"45","author":"SK Eskandari","year":"2024","unstructured":"Eskandari, S. K., Daccache, A. & Azzi, J. R. Chimeric antigen receptor T(reg) therapy in transplantation. Trends Immunol. 45, 48\u201361 (2024).","journal-title":"Trends Immunol."},{"key":"2910_CR271","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1172\/JCI82771","volume":"126","author":"KG MacDonald","year":"2016","unstructured":"MacDonald, K. G. et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J. Clin. Invest. 126, 1413\u20131424 (2016).","journal-title":"J. Clin. Invest."},{"key":"2910_CR272","doi-asserted-by":"publisher","first-page":"102961","DOI":"10.1016\/j.jaut.2022.102961","volume":"134","author":"DA Boardman","year":"2023","unstructured":"Boardman, D. A. et al. Flagellin-specific human CAR Tregs for immune regulation in IBD. J. Autoimmun. 134, 102961 (2023).","journal-title":"J. Autoimmun."},{"key":"2910_CR273","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03262-w","volume":"21","author":"J Frikeche","year":"2024","unstructured":"Frikeche, J. et al. MOG-specific CAR Tregs: a novel approach to treat multiple sclerosis. J. Neuroinflammation 21, 268 (2024).","journal-title":"J. Neuroinflammation"},{"key":"2910_CR274","first-page":"e168601","volume":"133","author":"JA Spanier","year":"2023","unstructured":"Spanier, J. A. et al. Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice. J. Clin. Invest. 133, e168601 (2023).","journal-title":"J. Clin. Invest."},{"key":"2910_CR275","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/biomedicines10020287","volume":"10","author":"M Arjomandnejad","year":"2022","unstructured":"Arjomandnejad, M., Kopec, A. L. & Keeler, A. M. CAR-T regulatory (CAR-Treg) cells: engineering and applications. Biomedicines 10, 287 (2022).","journal-title":"Biomedicines"},{"key":"2910_CR276","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-112","volume":"9","author":"M Fransson","year":"2012","unstructured":"Fransson, M. et al. CAR\/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery. J. Neuroinflammation 9, 112 (2012).","journal-title":"J. Neuroinflammation"},{"key":"2910_CR277","doi-asserted-by":"publisher","first-page":"e2416066","DOI":"10.1002\/advs.202416066","volume":"12","author":"N Sun","year":"2025","unstructured":"Sun, N. et al. Nanoneedle-based electroporation for efficient manufacturing of human primary chimeric antigen receptor regulatory T-cells. Adv. Sci. 12, e2416066 (2025).","journal-title":"Adv. Sci."},{"key":"2910_CR278","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cell.2016.09.050","volume":"167","author":"P Bacher","year":"2016","unstructured":"Bacher, P. et al. Regulatory T cell specificity directs tolerance versus allergy against aeroantigens in humans. Cell 167, 1067\u20131078.e1016 (2016).","journal-title":"Cell"},{"key":"2910_CR279","doi-asserted-by":"publisher","first-page":"e126194","DOI":"10.1172\/jci.insight.126194","volume":"5","author":"AC Boroughs","year":"2019","unstructured":"Boroughs, A. C. et al. Chimeric antigen receptor costimulation domains modulate human regulatory T cell function. JCI Insight 5, e126194 (2019).","journal-title":"JCI Insight"},{"key":"2910_CR280","doi-asserted-by":"publisher","first-page":"e2219086120","DOI":"10.1073\/pnas.2219086120","volume":"120","author":"C Lamarche","year":"2023","unstructured":"Lamarche, C. et al. Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion. Proc. Natl. Acad. Sci. USA. 120, e2219086120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR281","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26844-1","volume":"12","author":"B Lamarth\u00e9e","year":"2021","unstructured":"Lamarth\u00e9e, B. et al. Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction. Nat. Commun. 12, 6446 (2021).","journal-title":"Nat. Commun."},{"key":"2910_CR282","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46448-9","volume":"15","author":"M Doglio","year":"2024","unstructured":"Doglio, M. et al. Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus. Nat. Commun. 15, 2542 (2024).","journal-title":"Nat. Commun."},{"key":"2910_CR283","doi-asserted-by":"publisher","first-page":"101385","DOI":"10.1016\/j.omtm.2024.101385","volume":"32","author":"RW Cochrane","year":"2024","unstructured":"Cochrane, R. W. et al. High-affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells. Mol. Ther. Methods Clin. Dev. 32, 101385 (2024).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2910_CR284","doi-asserted-by":"publisher","first-page":"e008417","DOI":"10.1136\/jitc-2023-008417","volume":"12","author":"K Grauwet","year":"2024","unstructured":"Grauwet, K. et al. Stealth transgenes enable CAR-T cells to evade host immune responses. J. Immunother. Cancer 12, e008417 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"2910_CR285","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41571-021-00476-2","volume":"18","author":"DL Wagner","year":"2021","unstructured":"Wagner, D. L. et al. Immunogenicity of CAR T cells in cancer therapy. Nat. Rev. Clin. Oncol. 18, 379\u2013393 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2910_CR286","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/mt.2014.41","volume":"22","author":"D Blat","year":"2014","unstructured":"Blat, D. et al. Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells. Mol. Ther. 22, 1018\u20131028 (2014).","journal-title":"Mol. Ther."},{"key":"2910_CR287","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fimmu.2019.00150","volume":"10","author":"DJ Wendering","year":"2019","unstructured":"Wendering, D. J. et al. The value of a rapid test of human regulatory T cell function needs to be revised. Front. Immunol. 10, 150 (2019).","journal-title":"Front. Immunol."},{"key":"2910_CR288","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775\u2013787 (2008).","journal-title":"Cell"},{"key":"2910_CR289","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00281-019-00741-8","volume":"41","author":"L G\u00f6schl","year":"2019","unstructured":"G\u00f6schl, L., Scheinecker, C. & Bonelli, M. Treg cells in autoimmunity: from identification to Treg-based therapies. Semin. Immunopathol. 41, 301\u2013314 (2019).","journal-title":"Semin. Immunopathol."},{"key":"2910_CR290","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/eji.201847659","volume":"49","author":"A Tanaka","year":"2019","unstructured":"Tanaka, A. & Sakaguchi, S. Targeting Treg cells in cancer immunotherapy. Eur. J. Immunol. 49, 1140\u20131146 (2019).","journal-title":"Eur. J. Immunol."},{"key":"2910_CR291","doi-asserted-by":"publisher","first-page":"e1006776","DOI":"10.1371\/journal.ppat.1006776","volume":"14","author":"KJ Hasenkrug","year":"2018","unstructured":"Hasenkrug, K. J., Chougnet, C. A. & Dittmer, U. Regulatory T cells in retroviral infections. PLoS Pathog. 14, e1006776 (2018).","journal-title":"PLoS Pathog."},{"key":"2910_CR292","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1007\/s11427-021-2187-3","volume":"66","author":"X Chi","year":"2023","unstructured":"Chi, X. et al. Innate and adaptive immune abnormalities underlying autoimmune diseases: the genetic connections. Sci. China Life Sci. 66, 1482\u20131517 (2023).","journal-title":"Sci. China Life Sci."},{"key":"2910_CR293","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.jaip.2023.04.018","volume":"11","author":"PE Gray","year":"2023","unstructured":"Gray, P. E. & David, C. Inborn errors of immunity and autoimmune disease. J. Allergy Clin. Immunol. Pract. 11, 1602\u20131622 (2023).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"2910_CR294","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/BOR.0000000000000630","volume":"31","author":"H Torres-Aguilar","year":"2019","unstructured":"Torres-Aguilar, H., Sosa-Luis, S. A. & Aguilar-Ruiz, S. R. Infections as triggers of flares in systemic autoimmune diseases: novel innate immunity mechanisms. Curr. Opin. Rheumatol. 31, 525\u2013531 (2019).","journal-title":"Curr. Opin. Rheumatol."},{"key":"2910_CR295","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/brain\/awad419","volume":"147","author":"J Cleaver","year":"2024","unstructured":"Cleaver, J. et al. The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity. Brain 147, 1130\u20131148 (2024).","journal-title":"Brain"},{"key":"2910_CR296","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1016\/j.cell.2021.05.045","volume":"184","author":"A Wagner","year":"2021","unstructured":"Wagner, A. et al. Metabolic modeling of single Th17 cells reveals regulators of autoimmunity. Cell 184, 4168\u20134185.e4121 (2021).","journal-title":"Cell"},{"key":"2910_CR297","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36594-x","volume":"14","author":"K Aso","year":"2023","unstructured":"Aso, K. et al. Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming. Nat. Commun. 14, 984 (2023).","journal-title":"Nat. Commun."},{"key":"2910_CR298","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.tibtech.2018.02.008","volume":"36","author":"AK Shakya","year":"2018","unstructured":"Shakya, A. K. & Nandakumar, K. S. Antigen-specific tolerization and targeted delivery as therapeutic strategies for autoimmune diseases. Trends Biotechnol. 36, 686\u2013699 (2018).","journal-title":"Trends Biotechnol."},{"key":"2910_CR299","doi-asserted-by":"publisher","first-page":"Itc81","DOI":"10.7326\/AITC202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou, M. & Ching, C. L. Systemic lupus erythematosus. Ann. Intern. Med. 172, Itc81\u2013itc96 (2020).","journal-title":"Ann. Intern. Med."},{"key":"2910_CR300","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/S0140-6736(24)00398-2","volume":"403","author":"A Hoi","year":"2024","unstructured":"Hoi, A., Igel, T., Mok, C. C. & Arnaud, L. Systemic lupus erythematosus. Lancet 403, 2326\u20132338 (2024).","journal-title":"Lancet"},{"key":"2910_CR301","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1172\/JCI78089","volume":"125","author":"JA Bluestone","year":"2015","unstructured":"Bluestone, J. A., Bour-Jordan, H., Cheng, M. & Anderson, M. T cells in the control of organ-specific autoimmunity. J. Clin. Invest. 125, 2250\u20132260 (2015).","journal-title":"J. Clin. Invest."},{"key":"2910_CR302","doi-asserted-by":"publisher","first-page":"1425847","DOI":"10.3389\/fimmu.2024.1425847","volume":"15","author":"J Huang","year":"2024","unstructured":"Huang, J. et al. Imbalance of Th17 cells, Treg cells and associated cytokines in patients with systemic lupus erythematosus: a meta-analysis. Front. Immunol. 15, 1425847 (2024).","journal-title":"Front. Immunol."},{"key":"2910_CR303","doi-asserted-by":"publisher","first-page":"i65","DOI":"10.1136\/ard.2009.117135","volume":"69","author":"M Bonelli","year":"2010","unstructured":"Bonelli, M., Smolen, J. S. & Scheinecker, C. Treg and lupus. Ann. Rheum. Dis. 69, i65\u2013i66 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"2910_CR304","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/stcltm\/szae044","volume":"13","author":"LTM Dao","year":"2024","unstructured":"Dao, L. T. M. et al. Current cell therapies for systemic lupus erythematosus. Stem Cells Transl. Med. 13, 859\u2013872 (2024).","journal-title":"Stem Cells Transl. Med."},{"key":"2910_CR305","doi-asserted-by":"publisher","first-page":"9953","DOI":"10.7150\/thno.63743","volume":"11","author":"HC Chuang","year":"2021","unstructured":"Chuang, H. C. et al. BPI overexpression suppresses Treg differentiation and induces exosome-mediated inflammation in systemic lupus erythematosus. Theranostics 11, 9953\u20139966 (2021).","journal-title":"Theranostics"},{"key":"2910_CR306","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3389\/fimmu.2020.01291","volume":"11","author":"S Makita","year":"2020","unstructured":"Makita, S. et al. RNA-binding protein ZFP36L2 downregulates helios expression and suppresses the function of regulatory T cells. Front. Immunol. 11, 1291 (2020).","journal-title":"Front. Immunol."},{"key":"2910_CR307","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","volume":"75","author":"C von Spee-Mayer","year":"2016","unstructured":"von Spee-Mayer, C. et al. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 75, 1407\u20131415 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"2910_CR308","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1136\/ard-2022-222501","volume":"81","author":"JY Humrich","year":"2022","unstructured":"Humrich, J. Y. et al. Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial. Ann. Rheum. Dis. 81, 1685\u20131694 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"2910_CR309","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/j.immuni.2024.07.016","volume":"57","author":"ME Raeber","year":"2024","unstructured":"Raeber, M. E. et al. Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics. Immunity 57, 2232\u20132250.e2210 (2024).","journal-title":"Immunity"},{"key":"2910_CR310","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13075-021-02535-6","volume":"23","author":"M Miao","year":"2021","unstructured":"Miao, M. et al. Therapeutic potential of targeting Tfr\/Tfh cell balance by low-dose-IL-2 in active SLE: a post hoc analysis from a double-blind RCT study. Arthritis Res. Ther. 23, 167 (2021).","journal-title":"Arthritis Res. Ther."},{"key":"2910_CR311","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/annrheumdis-2014-206506","volume":"74","author":"JY Humrich","year":"2015","unstructured":"Humrich, J. Y. et al. Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE. Ann. Rheum. Dis. 74, 791\u2013792 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"2910_CR312","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12865-019-0305-0","volume":"20","author":"C Zhao","year":"2019","unstructured":"Zhao, C. et al. Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17\/Treg cells in refractory SLE patients. BMC Immunol. 20, 32 (2019).","journal-title":"BMC Immunol."},{"key":"2910_CR313","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41574-019-0254-y","volume":"15","author":"J Ilonen","year":"2019","unstructured":"Ilonen, J., Lempainen, J. & Veijola, R. The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat. Rev. Endocrinol. 15, 635\u2013650 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2910_CR314","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/ijms23010390","volume":"23","author":"I Ben-Skowronek","year":"2021","unstructured":"Ben-Skowronek, I. et al. Potential therapeutic application of regulatory T cells in diabetes mellitus type 1. Int. J. Mol. Sci. 23, 390 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2910_CR315","doi-asserted-by":"publisher","first-page":"722","DOI":"10.2337\/db21-0728","volume":"71","author":"YF Liu","year":"2022","unstructured":"Liu, Y. F. et al. Immune and metabolic effects of antigen-specific immunotherapy using multiple \u03b2-cell peptides in type 1. Diabetes Diabetes 71, 722\u2013732 (2022).","journal-title":"Diabetes Diabetes"},{"key":"2910_CR316","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13587-3","volume":"10","author":"MG Scherm","year":"2019","unstructured":"Scherm, M. G. et al. miRNA142-3p targets Tet2 and impairs Treg differentiation and stability in models of type 1 diabetes. Nat. Commun. 10, 5697 (2019).","journal-title":"Nat. Commun."},{"key":"2910_CR317","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10991","volume":"7","author":"I Serr","year":"2016","unstructured":"Serr, I. et al. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice. Nat. Commun. 7, 10991 (2016).","journal-title":"Nat. Commun."},{"key":"2910_CR318","doi-asserted-by":"publisher","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","volume":"7","author":"JA Bluestone","year":"2015","unstructured":"Bluestone, J. A. et al. Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci. Transl. Med. 7, 315ra189 (2015).","journal-title":"Sci. Transl. Med."},{"key":"2910_CR319","doi-asserted-by":"crossref","unstructured":"Dong, S. et al. The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes. JCI Insight 6, e147474 (2021).","DOI":"10.1172\/jci.insight.147474"},{"key":"2910_CR320","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2337\/dc12-0038","volume":"35","author":"N Marek-Trzonkowska","year":"2012","unstructured":"Marek-Trzonkowska, N. et al. Administration of CD4+CD25highCD127- regulatory T cells preserves \u03b2-cell function in type 1 diabetes in children. Diabetes Care 35, 1817\u20131820 (2012).","journal-title":"Diabetes Care"},{"key":"2910_CR321","doi-asserted-by":"publisher","first-page":"eadn2404","DOI":"10.1126\/scitranslmed.adn2404","volume":"16","author":"C Bender","year":"2024","unstructured":"Bender, C. et al. A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes. Sci. Transl. Med. 16, eadn2404 (2024).","journal-title":"Sci. Transl. Med."},{"key":"2910_CR322","doi-asserted-by":"crossref","unstructured":"Uenishi, G. I. et al. GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes. JCI Insight 9, e171844 (2024).","DOI":"10.1172\/jci.insight.171844"},{"key":"2910_CR323","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.molmed.2009.12.003","volume":"16","author":"K Venken","year":"2010","unstructured":"Venken, K., Hellings, N., Liblau, R. & Stinissen, P. Disturbed regulatory T cell homeostasis in multiple sclerosis. Trends Mol. Med. 16, 58\u201368 (2010).","journal-title":"Trends Mol. Med."},{"key":"2910_CR324","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1084\/jem.20031579","volume":"199","author":"V Viglietta","year":"2004","unstructured":"Viglietta, V., Baecher-Allan, C., Weiner, H. L. & Hafler, D. A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971\u2013979 (2004).","journal-title":"J. Exp. Med."},{"key":"2910_CR325","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","volume":"19","author":"M Dominguez-Villar","year":"2018","unstructured":"Dominguez-Villar, M. & Hafler, D. A. Regulatory T cells in autoimmune disease. Nat. Immunol. 19, 665\u2013673 (2018).","journal-title":"Nat. Immunol."},{"key":"2910_CR326","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nm.3411","volume":"20","author":"F Carbone","year":"2014","unstructured":"Carbone, F. et al. Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat. Med. 20, 69\u201374 (2014).","journal-title":"Nat. Med."},{"key":"2910_CR327","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1172\/JCI24685","volume":"115","author":"SE Allan","year":"2005","unstructured":"Allan, S. E. et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J. Clin. Invest. 115, 3276\u20133284 (2005).","journal-title":"J. Clin. Invest."},{"key":"2910_CR328","doi-asserted-by":"publisher","first-page":"eadp1720","DOI":"10.1126\/scitranslmed.adp1720","volume":"16","author":"TS Sumida","year":"2024","unstructured":"Sumida, T. S. et al. An autoimmune transcriptional circuit drives FOXP3(+) regulatory T cell dysfunction. Sci. Transl. Med. 16, eadp1720 (2024).","journal-title":"Sci. Transl. Med."},{"key":"2910_CR329","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acsnano.3c09225","volume":"18","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Immunoswitch nanomodulators enable active targeting and selective proliferation of regulatory T cells for multiple sclerosis therapy. ACS Nano 18, 770\u2013782 (2024).","journal-title":"ACS Nano"},{"key":"2910_CR330","doi-asserted-by":"publisher","first-page":"121517","DOI":"10.1016\/j.biomaterials.2022.121517","volume":"285","author":"Q Guo","year":"2022","unstructured":"Guo, Q. et al. Engineered PD-1\/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T cell\/Treg balance and alleviate systemic lupus erythematosus. Biomaterials 285, 121517 (2022).","journal-title":"Biomaterials"},{"key":"2910_CR331","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","volume":"365","author":"D Saadoun","year":"2011","unstructured":"Saadoun, D. et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N. Engl. J. Med. 365, 2067\u20132077 (2011).","journal-title":"N. Engl. J. Med."},{"key":"2910_CR332","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40259-020-00462-7","volume":"35","author":"K Chwojnicki","year":"2021","unstructured":"Chwojnicki, K. et al. Administration of CD4(+)CD25(high)CD127(-)FoxP3(+) regulatory T cells for relapsing-remitting multiple sclerosis: a phase 1 study. BioDrugs 35, 47\u201360 (2021).","journal-title":"BioDrugs"},{"key":"2910_CR333","doi-asserted-by":"publisher","first-page":"a032029","DOI":"10.1101\/cshperspect.a032029","volume":"8","author":"S Katsavos","year":"2018","unstructured":"Katsavos, S. & Coles, A. Alemtuzumab as treatment for multiple sclerosis. Cold Spring Harb. Perspect. Med. 8, a032029 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2910_CR334","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01847-9","volume":"17","author":"W Gilmore","year":"2020","unstructured":"Gilmore, W. et al. Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis. J. Neuroinflammation 17, 189 (2020).","journal-title":"J. Neuroinflammation"},{"key":"2910_CR335","doi-asserted-by":"publisher","first-page":"1000152","DOI":"10.4172\/2155-9899.1000152","volume":"4","author":"MS Freedman","year":"2013","unstructured":"Freedman, M. S., Kaplan, J. M. & Markovic-Plese, S. Insights into the mechanisms of the therapeutic efficacy of alemtuzumab in multiple sclerosis. J. Clin. Cell. Immunol. 4, 1000152 (2013).","journal-title":"J. Clin. Cell. Immunol."},{"key":"2910_CR336","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1002\/eji.200535075","volume":"35","author":"AL Cox","year":"2005","unstructured":"Cox, A. L. et al. Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis. Eur. J. Immunol. 35, 3332\u20133342 (2005).","journal-title":"Eur. J. Immunol."},{"key":"2910_CR337","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1212\/NXI.0000000000000194","volume":"3","author":"S De Mercanti","year":"2016","unstructured":"De Mercanti, S. et al. Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months. Neurol. Neuroimmunol. Neuroinflamm. 3, e194 (2016).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"2910_CR338","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.expneurol.2014.04.018","volume":"262 Pt A","author":"JL Jones","year":"2014","unstructured":"Jones, J. L. & Coles, A. J. Mode of action and clinical studies with alemtuzumab. Exp. Neurol. 262 Pt A, 37\u201343 (2014).","journal-title":"Exp. Neurol."},{"key":"2910_CR339","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen, J. S., Aletaha, D. & McInnes, I. B. Rheumatoid arthritis. Lancet 388, 2023\u20132038 (2016).","journal-title":"Lancet"},{"key":"2910_CR340","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMra2103726","volume":"388","author":"EM Gravallese","year":"2023","unstructured":"Gravallese, E. M. & Firestein, G. S. Rheumatoid arthritis \u2014 common origins, divergent mechanisms. N. Engl. J. Med. 388, 529\u2013542 (2023).","journal-title":"N. Engl. J. Med."},{"key":"2910_CR341","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1001\/jama.2022.0786","volume":"327","author":"MH Smith","year":"2022","unstructured":"Smith, M. H. & Berman, J. R. What is rheumatoid arthritis? JAMA 327, 1194 (2022).","journal-title":"JAMA"},{"key":"2910_CR342","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41588-022-01032-z","volume":"54","author":"K Ishigaki","year":"2022","unstructured":"Ishigaki, K. et al. HLA autoimmune risk alleles restrict the hypervariable region of T cell receptors. Nat. Genet. 54, 393\u2013402 (2022).","journal-title":"Nat. Genet."},{"key":"2910_CR343","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000493390","volume":"27","author":"J Bullock","year":"2018","unstructured":"Bullock, J. et al. Rheumatoid arthritis: a brief overview of the treatment. Med. Princ. Pract. 27, 501\u2013507 (2018).","journal-title":"Med. Princ. Pract."},{"key":"2910_CR344","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/apm.12154","volume":"122","author":"A Ebringer","year":"2014","unstructured":"Ebringer, A. & Rashid, T. Rheumatoid arthritis is caused by a Proteus urinary tract infection. APMIS 122, 363\u2013368 (2014).","journal-title":"APMIS"},{"key":"2910_CR345","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cellimm.2008.05.007","volume":"253","author":"GM Han","year":"2008","unstructured":"Han, G. M., O\u2019Neil-Andersen, N. J., Zurier, R. B. & Lawrence, D. A. CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell. Immunol. 253, 92\u2013101 (2008).","journal-title":"Cell. Immunol."},{"key":"2910_CR346","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1002\/art.20499","volume":"50","author":"JM van Amelsfort","year":"2004","unstructured":"van Amelsfort, J. M. et al. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 50, 2775\u20132785 (2004).","journal-title":"Arthritis Rheum."},{"key":"2910_CR347","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1365-3083.2005.01656.x","volume":"62","author":"MF Liu","year":"2005","unstructured":"Liu, M. F. et al. The presence of cytokine-suppressive CD4+CD25+T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis. Scand. J. Immunol. 62, 312\u2013317 (2005).","journal-title":"Scand. J. Immunol."},{"key":"2910_CR348","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2249.2005.02754.x","volume":"140","author":"M M\u00f6tt\u00f6nen","year":"2005","unstructured":"M\u00f6tt\u00f6nen, M. et al. CD4+CD25+T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin. Exp. Immunol. 140, 360\u2013367 (2005).","journal-title":"Clin. Exp. Immunol."},{"key":"2910_CR349","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s10875-011-9542-6","volume":"31","author":"C Lina","year":"2011","unstructured":"Lina, C., Conghua, W., Nan, L. & Ping, Z. Combined treatment of etanercept and MTX reverses Th1\/Th2, Th17\/Treg imbalance in patients with rheumatoid arthritis. J. Clin. Immunol. 31, 596\u2013605 (2011).","journal-title":"J. Clin. Immunol."},{"key":"2910_CR350","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3899\/jrheum.110283","volume":"38","author":"SY Kawashiri","year":"2011","unstructured":"Kawashiri, S. Y. et al. CD4+CD25(high)CD127(low\/-) Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis. J. Rheumatol. 38, 2517\u20132521 (2011).","journal-title":"J. Rheumatol."},{"key":"2910_CR351","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3899\/jrheum.110283","volume":"38","author":"SY Kawashiri","year":"2011","unstructured":"Kawashiri, S. Y. et al. CD4+CD25 highCD127 low\/- Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis. J. Rheumatol. 38, 2517\u20132521 (2011).","journal-title":"J. Rheumatol."},{"key":"2910_CR352","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/ar4545","volume":"16","author":"B Moradi","year":"2014","unstructured":"Moradi, B. et al. CD4\u207aCD25\u207a\/highCD127low\/\u207b regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints-analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood. Arthritis Res. Ther. 16, R97 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"2910_CR353","doi-asserted-by":"publisher","first-page":"R335","DOI":"10.1186\/ar1192","volume":"6","author":"D Cao","year":"2004","unstructured":"Cao, D. et al. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 6, R335\u2013R346 (2004).","journal-title":"Arthritis Res. Ther."},{"key":"2910_CR354","doi-asserted-by":"publisher","first-page":"626193","DOI":"10.3389\/fimmu.2021.626193","volume":"12","author":"Q Jiang","year":"2021","unstructured":"Jiang, Q. et al. Function and role of regulatory T cells in rheumatoid arthritis. Front. Immunol. 12, 626193 (2021).","journal-title":"Front. Immunol."},{"key":"2910_CR355","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.imlet.2018.10.001","volume":"204","author":"V Hashemi","year":"2018","unstructured":"Hashemi, V. et al. Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population. Immunol. Lett. 204, 16\u201322 (2018).","journal-title":"Immunol. Lett."},{"key":"2910_CR356","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1073\/pnas.0806855105","volume":"105","author":"F Flores-Borja","year":"2008","unstructured":"Flores-Borja, F., Jury, E. C., Mauri, C. & Ehrenstein, M. R. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 105, 19396\u201319401 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR357","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1007\/s10753-017-0577-6","volume":"40","author":"H Sun","year":"2017","unstructured":"Sun, H. et al. Tim3(+) Foxp3 (+) Treg cells are potent inhibitors of effector T cells and are suppressed in rheumatoid arthritis. Inflammation 40, 1342\u20131350 (2017).","journal-title":"Inflammation"},{"key":"2910_CR358","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","volume":"20","author":"N Komatsu","year":"2014","unstructured":"Komatsu, N. et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat. Med. 20, 62\u201368 (2014).","journal-title":"Nat. Med."},{"key":"2910_CR359","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1002\/art.23138","volume":"56","author":"MM Zaiss","year":"2007","unstructured":"Zaiss, M. M. et al. Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum. 56, 4104\u20134112 (2007).","journal-title":"Arthritis Rheum."},{"key":"2910_CR360","doi-asserted-by":"publisher","first-page":"947341","DOI":"10.3389\/fimmu.2022.947341","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Low-dose IL-2 improved clinical symptoms by restoring reduced regulatory T cells in patients with refractory rheumatoid arthritis: A randomized controlled trial. Front. Immunol. 13, 947341 (2022).","journal-title":"Front. Immunol."},{"key":"2910_CR361","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41392-022-00887-2","volume":"7","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct. Target. Ther. 7, 67 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2910_CR362","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1194\/jlr.M010876","volume":"52","author":"TT Tang","year":"2011","unstructured":"Tang, T. T. et al. Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis. J. Lipid Res. 52, 1023\u20131032 (2011).","journal-title":"J. Lipid Res."},{"key":"2910_CR363","doi-asserted-by":"publisher","first-page":"1359041","DOI":"10.3389\/fimmu.2024.1359041","volume":"15","author":"SX Zhang","year":"2024","unstructured":"Zhang, S. X. et al. The efficacy and safety of short-term and low-dose IL-2 combined with tocilizumab to treat rheumatoid arthritis. Front. Immunol. 15, 1359041 (2024).","journal-title":"Front. Immunol."},{"key":"2910_CR364","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. Downregulation of N6-methyladenosine (m6A) methylation of Sema4D mRNA contributes to Treg dysfunction and allograft rejection. Am. J. Transplant. 25, 930\u2013942 (2025).","DOI":"10.1016\/j.ajt.2025.01.017"},{"key":"2910_CR365","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jtos.2023.09.006","volume":"30","author":"P Steven","year":"2023","unstructured":"Steven, P., Perez, V. L. & Sharma, A. Murine models of graft versus host disease (GVHD): focus on ocular GVHD. Ocul. Surf. 30, 179\u2013186 (2023).","journal-title":"Ocul. Surf."},{"key":"2910_CR366","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1182\/blood.2024026446","volume":"145","author":"EH Meyer","year":"2025","unstructured":"Meyer, E. H. et al. Donor regulatory T-cell therapy to prevent graft-versus-host disease. Blood 145, 2012\u20132024 (2025).","journal-title":"Blood"},{"key":"2910_CR367","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser, R. & Blazar, B. R. Acute graft-versus-host disease - biologic process, prevention, and therapy. N. Engl. J. Med. 377, 2167\u20132179 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2910_CR368","doi-asserted-by":"publisher","first-page":"e2205062119","DOI":"10.1073\/pnas.2205062119","volume":"119","author":"PK Gupta","year":"2022","unstructured":"Gupta, P. K. et al. Reduced Satb1 expression predisposes CD4(+) T conventional cells to Treg suppression and promotes transplant survival. Proc. Natl. Acad. Sci. USA. 119, e2205062119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR369","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41423-019-0203-7","volume":"16","author":"PK Gupta","year":"2019","unstructured":"Gupta, P. K., McIntosh, C. M., Chong, A. S. & Alegre, M. L. The pursuit of transplantation tolerance: new mechanistic insights. Cell. Mol. Immunol. 16, 324\u2013333 (2019).","journal-title":"Cell. Mol. Immunol."},{"key":"2910_CR370","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8566","volume":"6","author":"ML Miller","year":"2015","unstructured":"Miller, M. L. et al. Spontaneous restoration of transplantation tolerance after acute rejection. Nat. Commun. 6, 7566 (2015).","journal-title":"Nat. Commun."},{"key":"2910_CR371","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1111\/ajt.15789","volume":"20","author":"JW Han","year":"2020","unstructured":"Han, J. W. et al. Early reduction of regulatory T cells is associated with acute rejection in liver transplantation under tacrolimus-based immunosuppression with basiliximab induction. Am. J. Transplant. 20, 2058\u20132069 (2020).","journal-title":"Am. J. Transplant."},{"key":"2910_CR372","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1111\/ajt.12445","volume":"13","author":"M Hu","year":"2013","unstructured":"Hu, M. et al. Infiltrating Foxp3(+) regulatory T cells from spontaneously tolerant kidney allografts demonstrate donor-specific tolerance. Am. J. Transplant. 13, 2819\u20132830 (2013).","journal-title":"Am. J. Transplant."},{"key":"2910_CR373","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1182\/blood-2016-02-702852","volume":"128","author":"J Koreth","year":"2016","unstructured":"Koreth, J. et al. Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease. Blood 128, 130\u2013137 (2016).","journal-title":"Blood"},{"key":"2910_CR374","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1182\/bloodadvances.2023011625","volume":"8","author":"CS Bader","year":"2024","unstructured":"Bader, C. S. et al. Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD. Blood Adv. 8, 1105\u20131115 (2024).","journal-title":"Blood Adv."},{"key":"2910_CR375","doi-asserted-by":"publisher","first-page":"m3734","DOI":"10.1136\/bmj.m3734","volume":"371","author":"A Roemhild","year":"2020","unstructured":"Roemhild, A. et al. Regulatory T cells for minimising immune suppression in kidney transplantation: phase I\/IIa clinical trial. BMJ 371, m3734 (2020).","journal-title":"BMJ"},{"key":"2910_CR376","doi-asserted-by":"publisher","first-page":"105239","DOI":"10.1016\/j.ebiom.2024.105239","volume":"106","author":"AF David","year":"2024","unstructured":"David, A. F. et al. Combination cell therapy leads to clonal deletion of donor-specific T cells in kidney transplant recipients. EBioMedicine 106, 105239 (2024).","journal-title":"EBioMedicine"},{"key":"2910_CR377","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/ajt.15700","volume":"20","author":"A S\u00e1nchez-Fueyo","year":"2020","unstructured":"S\u00e1nchez-Fueyo, A. et al. Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation. Am. J. Transpl. 20, 1125\u20131136 (2020).","journal-title":"Am. J. Transpl."},{"key":"2910_CR378","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1111\/ajt.17101","volume":"22","author":"R Ravichandran","year":"2022","unstructured":"Ravichandran, R. et al. Low-dose IL-2 prevents murine chronic cardiac allograft rejection: Role for IL-2-induced T regulatory cells and exosomes with PD-L1 and CD73. Am. J. Transplant. 22, 2180\u20132194 (2022).","journal-title":"Am. J. Transplant."},{"key":"2910_CR379","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/TP.0000000000001044","volume":"100","author":"M Tahvildari","year":"2016","unstructured":"Tahvildari, M. et al. In vivo expansion of regulatory T cells by low-dose interleukin-2 treatment increases allograft survival in corneal transplantation. Transplantation 100, 525\u2013532 (2016).","journal-title":"Transplantation"},{"key":"2910_CR380","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1073\/pnas.1620835114","volume":"114","author":"G Whitehouse","year":"2017","unstructured":"Whitehouse, G. et al. IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors. Proc. Natl. Acad. Sci. USA. 114, 7083\u20137088 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR381","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1084\/jem.20082824","volume":"206","author":"KE Webster","year":"2009","unstructured":"Webster, K. E. et al. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206, 751\u2013760 (2009).","journal-title":"J. Exp. Med."},{"key":"2910_CR382","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36924-z","volume":"14","author":"Y Yamada","year":"2023","unstructured":"Yamada, Y. et al. Biased IL-2 signals induce Foxp3-rich pulmonary lymphoid structures and facilitate long-term lung allograft acceptance in mice. Nat. Commun. 14, 1383 (2023).","journal-title":"Nat. Commun."},{"key":"2910_CR383","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jhep.2022.08.035","volume":"78","author":"TY Lim","year":"2023","unstructured":"Lim, T. Y. et al. Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans. J. Hepatol. 78, 153\u2013164 (2023).","journal-title":"J. Hepatol."},{"key":"2910_CR384","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/all.16326","volume":"80","author":"ML Conrad","year":"2024","unstructured":"Conrad, M. L. et al. Regulatory T cells and their role in allergic disease. Allergy 80, 77\u201393 (2024).","journal-title":"Allergy"},{"key":"2910_CR385","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/nri2870","volume":"10","author":"CM Lloyd","year":"2010","unstructured":"Lloyd, C. M. & Hessel, E. M. Functions of T cells in asthma: more than just T(H)2 cells. Nat. Rev. Immunol. 10, 838\u2013848 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"2910_CR386","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41590-020-0777-3","volume":"21","author":"H Harb","year":"2020","unstructured":"Harb, H. et al. A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Nat. Immunol. 21, 1359\u20131370 (2020).","journal-title":"Nat. Immunol."},{"key":"2910_CR387","doi-asserted-by":"publisher","first-page":"2301752","DOI":"10.1183\/13993003.01752-2023","volume":"64","author":"A Aili","year":"2024","unstructured":"Aili, A. et al. LPG 18:0 is a general biomarker of asthma and inhibits the differentiation and function of regulatory T-cells. Eur. Respir. J. 64, 2301752 (2024).","journal-title":"Eur. Respir. J."},{"key":"2910_CR388","doi-asserted-by":"publisher","first-page":"7539","DOI":"10.4049\/jimmunol.0804225","volume":"182","author":"JT Bates","year":"2009","unstructured":"Bates, J. T., Uematsu, S., Akira, S. & Mizel, S. B. Direct stimulation of tlr5+\/+ CD11c+ cells is necessary for the adjuvant activity of flagellin. J. Immunol. 182, 7539\u20137547 (2009).","journal-title":"J. Immunol."},{"key":"2910_CR389","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jaci.2015.07.010","volume":"137","author":"JU Shim","year":"2016","unstructured":"Shim, J. U. et al. Flagellin suppresses experimental asthma by generating regulatory dendritic cells and T cells. J. Allergy Clin. Immunol. 137, 426\u2013435 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2910_CR390","doi-asserted-by":"publisher","first-page":"e2412543","DOI":"10.1002\/advs.202412543","volume":"12","author":"F Wang","year":"2025","unstructured":"Wang, F. et al. A spleen-targeted tolerogenic mRNA-LNPs vaccine for the treatment of experimental asthma. Adv. Sci. 12, e2412543 (2025).","journal-title":"Adv. Sci."},{"key":"2910_CR391","doi-asserted-by":"publisher","first-page":"eadc9324","DOI":"10.1126\/sciimmunol.adc9324","volume":"8","author":"T Shirai","year":"2023","unstructured":"Shirai, T. et al. Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3\/8 complex. Sci. Immunol. 8, eadc9324 (2023).","journal-title":"Sci. Immunol."},{"key":"2910_CR392","doi-asserted-by":"publisher","first-page":"103479","DOI":"10.1016\/j.isci.2021.103479","volume":"24","author":"S Ndeupen","year":"2021","unstructured":"Ndeupen, S. et al. The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. iScience 24, 103479 (2021).","journal-title":"iScience"},{"key":"2910_CR393","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1158\/0008-5472.CAN-17-3102","volume":"78","author":"S Hibino","year":"2018","unstructured":"Hibino, S. et al. Inhibition of Nr4a receptors enhances antitumor immunity by breaking Treg-mediated immune tolerance. Cancer Res. 78, 3027\u20133040 (2018).","journal-title":"Cancer Res."},{"key":"2910_CR394","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","volume":"41","author":"C Tay","year":"2023","unstructured":"Tay, C., Tanaka, A. & Sakaguchi, S. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell 41, 450\u2013465 (2023).","journal-title":"Cancer Cell"},{"key":"2910_CR395","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.immuni.2017.03.013","volume":"46","author":"F Arce Vargas","year":"2017","unstructured":"Arce Vargas, F. et al. Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors. Immunity 46, 577\u2013586 (2017).","journal-title":"Immunity"},{"key":"2910_CR396","doi-asserted-by":"publisher","first-page":"699895","DOI":"10.3389\/fimmu.2021.699895","volume":"12","author":"Z Ge","year":"2021","unstructured":"Ge, Z., Peppelenbosch, M. P., Sprengers, D. & Kwekkeboom, J. TIGIT, the next step towards successful combination immune checkpoint therapy in cancer. Front. Immunol. 12, 699895 (2021).","journal-title":"Front. Immunol."},{"key":"2910_CR397","doi-asserted-by":"publisher","first-page":"17945","DOI":"10.1073\/pnas.1316796110","volume":"110","author":"D Sugiyama","year":"2013","unstructured":"Sugiyama, D. et al. Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. Proc. Natl. Acad. Sci. USA. 110, 17945\u201317950 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR398","doi-asserted-by":"publisher","first-page":"e2114282119","DOI":"10.1073\/pnas.2114282119","volume":"119","author":"Y Kidani","year":"2022","unstructured":"Kidani, Y. et al. CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory. Proc. Natl. Acad. Sci. USA. 119, e2114282119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR399","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41586-022-04685-2","volume":"605","author":"S Eschweiler","year":"2022","unstructured":"Eschweiler, S. et al. Intermittent PI3K\u03b4 inhibition sustains anti-tumour immunity and curbs irAEs. Nature 605, 741\u2013746 (2022).","journal-title":"Nature"},{"key":"2910_CR400","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1158\/2159-8290.CD-19-0958","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Regulatory T-cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis. Cancer Discov. 10, 422\u2013439 (2020).","journal-title":"Cancer Discov."},{"key":"2910_CR401","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cmet.2023.12.019","volume":"36","author":"M Becker","year":"2024","unstructured":"Becker, M. et al. Niche-specific control of tissue function by regulatory T cells-Current challenges and perspectives for targeting metabolic disease. Cell Metab. 36, 229\u2013239 (2024).","journal-title":"Cell Metab."},{"key":"2910_CR402","doi-asserted-by":"publisher","first-page":"eaay6191","DOI":"10.1126\/sciadv.aay6191","volume":"6","author":"XY Zhao","year":"2020","unstructured":"Zhao, X. Y. et al. The obesity-induced adipokine sST2 exacerbates adipose T(reg) and ILC2 depletion and promotes insulin resistance. Sci. Adv. 6, eaay6191 (2020).","journal-title":"Sci. Adv."},{"key":"2910_CR403","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1016\/j.celrep.2018.11.083","volume":"25","author":"J Gilleron","year":"2018","unstructured":"Gilleron, J. et al. Rab4b deficiency in T cells promotes adipose Treg\/Th17 imbalance, adipose tissue dysfunction, and insulin resistance. Cell Rep. 25, 3329\u20133341.e3325 (2018).","journal-title":"Cell Rep."},{"key":"2910_CR404","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.immuni.2024.04.002","volume":"57","author":"G Wang","year":"2024","unstructured":"Wang, G. et al. Adipose-tissue Treg cells restrain differentiation of stromal adipocyte precursors to promote insulin sensitivity and metabolic homeostasis. Immunity 57, 1345\u20131359.e1345 (2024).","journal-title":"Immunity"},{"key":"2910_CR405","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.immuni.2019.03.014","volume":"50","author":"L Schmidleithner","year":"2019","unstructured":"Schmidleithner, L. et al. Enzymatic activity of HPGD in Treg cells suppresses Tconv cells to maintain adipose tissue homeostasis and prevent metabolic dysfunction. Immunity 50, 1232\u20131248.e1214 (2019).","journal-title":"Immunity"},{"key":"2910_CR406","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cmet.2014.05.005","volume":"20","author":"I Wernstedt Asterholm","year":"2014","unstructured":"Wernstedt Asterholm, I. et al. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab. 20, 103\u2013118 (2014).","journal-title":"Cell Metab."},{"key":"2910_CR407","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51353-2","volume":"15","author":"B Nayer","year":"2024","unstructured":"Nayer, B. et al. Local administration of regulatory T cells promotes tissue healing. Nat. Commun. 15, 7863 (2024).","journal-title":"Nat. Commun."},{"key":"2910_CR408","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10160","volume":"474","author":"J Fujisaki","year":"2011","unstructured":"Fujisaki, J. et al. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474, 216\u2013219 (2011).","journal-title":"Nature"},{"key":"2910_CR409","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3389\/fimmu.2018.00585","volume":"9","author":"J Li","year":"2018","unstructured":"Li, J., Tan, J., Martino, M. M. & Lui, K. O. Regulatory T-cells: potential regulator of tissue repair and regeneration. Front. Immunol. 9, 585 (2018).","journal-title":"Front. Immunol."},{"key":"2910_CR410","doi-asserted-by":"publisher","first-page":"e20231244","DOI":"10.1084\/jem.20231244","volume":"221","author":"LF Loffredo","year":"2024","unstructured":"Loffredo, L. F., Savage, T. M., Ringham, O. R. & Arpaia, N. Treg-tissue cell interactions in repair and regeneration. J. Exp. Med. 221, e20231244 (2024).","journal-title":"J. Exp. Med."},{"key":"2910_CR411","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.immuni.2021.03.007","volume":"54","author":"M Delacher","year":"2021","unstructured":"Delacher, M. et al. Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells. Immunity 54, 702\u2013720.e717 (2021).","journal-title":"Immunity"},{"key":"2910_CR412","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.immuni.2019.12.002","volume":"52","author":"M Delacher","year":"2020","unstructured":"Delacher, M. et al. Precursors for nonlymphoid-tissue Treg cells reside in secondary lymphoid organs and are programmed by the transcription factor BATF. Immunity 52, 295\u2013312.e211 (2020).","journal-title":"Immunity"},{"key":"2910_CR413","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09276-w","volume":"10","author":"M Delacher","year":"2019","unstructured":"Delacher, M. et al. Rbpj expression in regulatory T cells is critical for restraining T(H)2 responses. Nat. Commun. 10, 1621 (2019).","journal-title":"Nat. Commun."},{"key":"2910_CR414","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ni.3799","volume":"18","author":"M Delacher","year":"2017","unstructured":"Delacher, M. et al. Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues. Nat. Immunol. 18, 1160\u20131172 (2017).","journal-title":"Nat. Immunol."},{"key":"2910_CR415","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/ni.3085","volume":"16","author":"A Vasanthakumar","year":"2015","unstructured":"Vasanthakumar, A. et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol. 16, 276\u2013285 (2015).","journal-title":"Nat. Immunol."},{"key":"2910_CR416","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature13577","volume":"513","author":"C Schiering","year":"2014","unstructured":"Schiering, C. et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564\u2013568 (2014).","journal-title":"Nature"},{"key":"2910_CR417","doi-asserted-by":"publisher","first-page":"e180679","DOI":"10.1172\/JCI180679","volume":"135","author":"R Chen","year":"2024","unstructured":"Chen, R. et al. Progranulin-dependent repair function of regulatory T cells drives bone-fracture healing. J. Clin. Invest. 135, e180679 (2024).","journal-title":"J. Clin. Invest."},{"key":"2910_CR418","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3389\/fimmu.2020.01142","volume":"11","author":"M Zhang","year":"2020","unstructured":"Zhang, M. & Zhang, S. T cells in fibrosis and fibrotic diseases. Front. Immunol. 11, 1142 (2020).","journal-title":"Front. Immunol."},{"key":"2910_CR419","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00395-011-0232-6","volume":"107","author":"TT Tang","year":"2012","unstructured":"Tang, T. T. et al. Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res. Cardiol. 107, 232 (2012).","journal-title":"Basic Res. Cardiol."},{"key":"2910_CR420","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50806-y","volume":"15","author":"YK Alshoubaki","year":"2024","unstructured":"Alshoubaki, Y. K. et al. Tregs delivered post-myocardial infarction adopt an injury-specific phenotype promoting cardiac repair via macrophages in mice. Nat. Commun. 15, 6480 (2024).","journal-title":"Nat. Commun."},{"key":"2910_CR421","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1161\/CIRCULATIONAHA.108.832782","volume":"119","author":"H Kvakan","year":"2009","unstructured":"Kvakan, H. et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 119, 2904\u20132912 (2009).","journal-title":"Circulation"},{"key":"2910_CR422","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1161\/CIRCULATIONAHA.118.036065","volume":"139","author":"SS Bansal","year":"2019","unstructured":"Bansal, S. S. et al. Dysfunctional and proinflammatory regulatory T-lymphocytes are essential for adverse cardiac remodeling in ischemic cardiomyopathy. Circulation 139, 206\u2013221 (2019).","journal-title":"Circulation"},{"key":"2910_CR423","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1164\/rccm.201103-0516OC","volume":"184","author":"S Lo Re","year":"2011","unstructured":"Lo Re, S. et al. Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis. Am. J. Respir. Crit. Care Med. 184, 1270\u20131281 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2910_CR424","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijrobp.2023.08.005","volume":"118","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Glycyrrhetinic acid mitigates radiation-induced pulmonary fibrosis via inhibiting the secretion of TGF-\u03b21 by Treg cells. Int. J. Radiat. Oncol. Biol. Phys. 118, 218\u2013230 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"2910_CR425","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.imbio.2015.07.001","volume":"220","author":"S Xiong","year":"2015","unstructured":"Xiong, S. et al. Treg depletion attenuates irradiation-induced pulmonary fibrosis by reducing fibrocyte accumulation, inducing Th17 response, and shifting IFN-\u03b3, IL-12\/IL-4, IL-5 balance. Immunobiology 220, 1284\u20131291 (2015).","journal-title":"Immunobiology"},{"key":"2910_CR426","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1089\/ars.2023.0387","volume":"41","author":"S Yan","year":"2024","unstructured":"Yan, S. et al. Low expression of lipoic acid synthase aggravates silica-induced pulmonary fibrosis by inhibiting the differentiation of Tregs in mice. Antioxid. Redox Signal 41, 216\u2013232 (2024).","journal-title":"Antioxid. Redox Signal"},{"key":"2910_CR427","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1021\/acs.jnatprod.5b00868","volume":"78","author":"T Liu","year":"2015","unstructured":"Liu, T. et al. Baicalin alleviates silica-induced lung inflammation and fibrosis by inhibiting the Th17 response in C57BL\/6 mice. J. Nat. Prod. 78, 3049\u20133057 (2015).","journal-title":"J. Nat. Prod."},{"key":"2910_CR428","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/art.42111","volume":"74","author":"C Frantz","year":"2022","unstructured":"Frantz, C. et al. Driving role of interleukin-2-related regulatory CD4+T cell deficiency in the development of lung fibrosis and vascular remodeling in a mouse model of systemic sclerosis. Arthritis Rheumatol. 74, 1387\u20131398 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"2910_CR429","doi-asserted-by":"publisher","first-page":"584048","DOI":"10.3389\/fimmu.2020.584048","volume":"11","author":"Y Ikeno","year":"2020","unstructured":"Ikeno, Y. et al. Foxp3+ regulatory T cells inhibit CCl(4)-induced liver inflammation and fibrosis by regulating tissue cellular immunity. Front. Immunol. 11, 584048 (2020).","journal-title":"Front. Immunol."},{"key":"2910_CR430","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.immuni.2024.01.009","volume":"57","author":"TM Savage","year":"2024","unstructured":"Savage, T. M. et al. Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis. Immunity 57, 303\u2013318.e306 (2024).","journal-title":"Immunity"},{"key":"2910_CR431","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","volume":"389","author":"MD Walker","year":"2023","unstructured":"Walker, M. D. & Shane, E. Postmenopausal osteoporosis. N. Engl. J. Med. 389, 1979\u20131991 (2023).","journal-title":"N. Engl. J. Med."},{"key":"2910_CR432","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1172\/JCI125915","volume":"129","author":"N Bonnet","year":"2019","unstructured":"Bonnet, N. et al. RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J. Clin. Invest. 129, 3214\u20133223 (2019).","journal-title":"J. Clin. Invest."},{"key":"2910_CR433","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3389\/fendo.2019.00578","volume":"10","author":"L Fischer","year":"2019","unstructured":"Fischer, L. et al. Foxp3(+) Regulatory T Cells in Bone and Hematopoietic Homeostasis. Front. Endocrinol. 10, 578 (2019).","journal-title":"Front. Endocrinol."},{"key":"2910_CR434","doi-asserted-by":"publisher","first-page":"e134092","DOI":"10.1172\/jci.insight.134092","volume":"5","author":"A Shieh","year":"2020","unstructured":"Shieh, A., Epeldegui, M., Karlamangla, A. S. & Greendale, G. A. Gut permeability, inflammation, and bone density across the menopause transition. JCI Insight 5, e134092 (2020).","journal-title":"JCI Insight"},{"key":"2910_CR435","first-page":"3150","volume":"6","author":"X Yang","year":"2021","unstructured":"Yang, X. et al. T cell-depleting nanoparticles ameliorate bone loss by reducing activated T cells and regulating the Treg\/Th17 balance. Bioact. Mater. 6, 3150\u20133163 (2021).","journal-title":"Bioact. Mater."},{"key":"2910_CR436","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/cmi.2010.54","volume":"8","author":"CY Luo","year":"2011","unstructured":"Luo, C. Y., Wang, L., Sun, C. & Li, D. J. Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro. Cell. Mol. Immunol. 8, 50\u201358 (2011).","journal-title":"Cell. Mol. Immunol."},{"key":"2910_CR437","doi-asserted-by":"publisher","first-page":"2190304","DOI":"10.1080\/19490976.2023.2190304","volume":"15","author":"M Guo","year":"2023","unstructured":"Guo, M. et al. Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17\/Treg balance and gut microbiota structure. Gut Microbes 15, 2190304 (2023).","journal-title":"Gut Microbes"},{"key":"2910_CR438","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bonr.2018.02.001","volume":"8","author":"HY Dar","year":"2018","unstructured":"Dar, H. Y. et al. Lactobacillus acidophilus inhibits bone loss and increases bone heterogeneity in osteoporotic mice via modulating Treg-Th17 cell balance. Bone Rep. 8, 46\u201356 (2018).","journal-title":"Bone Rep."},{"key":"2910_CR439","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","volume":"1","author":"A Hartemann","year":"2013","unstructured":"Hartemann, A. et al. Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 1, 295\u2013305 (2013).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2910_CR440","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","volume":"79","author":"J He","year":"2020","unstructured":"He, J. et al. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. Ann. Rheum. Dis. 79, 141\u2013149 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"2910_CR441","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1002\/eji.202049123","volume":"51","author":"V Saxena","year":"2021","unstructured":"Saxena, V., Lakhan, R., Iyyathurai, J. & Bromberg, J. S. Mechanisms of exTreg induction. Eur. J. Immunol. 51, 1956\u20131967 (2021).","journal-title":"Eur. J. Immunol."},{"key":"2910_CR442","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4049\/jimmunol.182.1.259","volume":"182","author":"G Lal","year":"2009","unstructured":"Lal, G. et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 182, 259\u2013273 (2009).","journal-title":"J. Immunol."},{"key":"2910_CR443","doi-asserted-by":"publisher","first-page":"783282","DOI":"10.3389\/fimmu.2021.783282","volume":"12","author":"N Skartsis","year":"2021","unstructured":"Skartsis, N. et al. IL-6 and TNF\u03b1 drive extensive proliferation of human Tregs without compromising their lineage stability or function. Front. Immunol. 12, 783282 (2021).","journal-title":"Front. Immunol."},{"key":"2910_CR444","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s44161-022-00063-3","volume":"1","author":"R Saigusa","year":"2022","unstructured":"Saigusa, R. et al. Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease. Nat. Cardiovasc. Res. 1, 462\u2013475 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"2910_CR445","doi-asserted-by":"publisher","first-page":"e179874","DOI":"10.1172\/JCI179874","volume":"135","author":"Z Jiang","year":"2024","unstructured":"Jiang, Z. et al. TMED4 facilitates regulatory T cell suppressive function via ROS homeostasis in tumor and autoimmune mouse models. J. Clin. Invest. 135, e179874 (2024).","journal-title":"J. Clin. Invest."},{"key":"2910_CR446","doi-asserted-by":"publisher","first-page":"e121887","DOI":"10.1172\/jci.insight.121887","volume":"4","author":"Y Xu","year":"2019","unstructured":"Xu, Y. et al. The E3 ligase Hrd1 stabilizes Tregs by antagonizing inflammatory cytokine-induced ER stress response. JCI Insight 4, e121887 (2019).","journal-title":"JCI Insight"},{"key":"2910_CR447","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/s41590-023-01589-9","volume":"24","author":"A Freuchet","year":"2023","unstructured":"Freuchet, A. et al. Identification of human exT(reg) cells as CD16(+)CD56(+) cytotoxic CD4(+) T cells. Nat. Immunol. 24, 1748\u20131761 (2023).","journal-title":"Nat. Immunol."},{"key":"2910_CR448","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cmet.2020.07.001","volume":"32","author":"T Alissafi","year":"2020","unstructured":"Alissafi, T. et al. Mitochondrial oxidative damage underlies regulatory T cell defects in autoimmunity. Cell Metab. 32, 591\u2013604.e597 (2020).","journal-title":"Cell Metab."},{"key":"2910_CR449","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1038\/s44321-025-00322-3","volume":"17","author":"S Parashar","year":"2025","unstructured":"Parashar, S. et al. ER stress induced mitochondrial dysfunction drives Treg instability in coronary artery disease. EMBO Mol. Med. 17, 3250\u20133274 (2025).","journal-title":"EMBO Mol. Med."},{"key":"2910_CR450","doi-asserted-by":"publisher","first-page":"e07571","DOI":"10.7554\/eLife.07571","volume":"4","author":"A Arvey","year":"2015","unstructured":"Arvey, A. et al. Genetic and epigenetic variation in the lineage specification of regulatory T cells. eLife 4, e07571 (2015).","journal-title":"eLife"},{"key":"2910_CR451","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1084\/jem.20120822","volume":"209","author":"M Yadav","year":"2012","unstructured":"Yadav, M. et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J. Exp. Med. 209, 1713\u20131722, s1711\u20131719 (2012).","journal-title":"J. Exp. Med."},{"key":"2910_CR452","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1084\/jem.20120914","volume":"209","author":"JM Weiss","year":"2012","unstructured":"Weiss, J. M. et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 209, 1723\u20131742, s1721 (2012).","journal-title":"J. Exp. Med."},{"key":"2910_CR453","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","volume":"184","author":"AM Thornton","year":"2010","unstructured":"Thornton, A. M. et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184, 3433\u20133441 (2010).","journal-title":"J. Immunol."},{"key":"2910_CR454","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2016.00276","volume":"7","author":"E Elkord","year":"2016","unstructured":"Elkord, E. Helios should not be cited as a marker of human thymus-derived Tregs. Commentary: helios(+) and helios(-) cells coexist within the natural FOXP3(+) T regulatory cell subset in humans. Front. Immunol. 7, 276 (2016).","journal-title":"Front. Immunol."},{"key":"2910_CR455","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1146\/annurev.immunol.24.021605.090547","volume":"24","author":"SF Ziegler","year":"2006","unstructured":"Ziegler, S. F. FOXP3: of mice and men. Annu. Rev. Immunol. 24, 209\u2013226 (2006).","journal-title":"Annu. Rev. Immunol."},{"key":"2910_CR456","doi-asserted-by":"publisher","first-page":"eabo5407","DOI":"10.1126\/sciimmunol.abo5407","volume":"7","author":"J Du","year":"2022","unstructured":"Du, J. et al. FOXP3 exon 2 controls T(reg) stability and autoimmunity. Sci. Immunol. 7, eabo5407 (2022).","journal-title":"Sci. Immunol."},{"key":"2910_CR457","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/icb.2010.137","volume":"89","author":"M Miyara","year":"2011","unstructured":"Miyara, M. & Sakaguchi, S. Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns. Immunol. Cell Biol. 89, 346\u2013351 (2011).","journal-title":"Immunol. Cell Biol."},{"key":"2910_CR458","doi-asserted-by":"publisher","first-page":"744763","DOI":"10.3389\/fimmu.2021.744763","volume":"12","author":"J Balcerek","year":"2021","unstructured":"Balcerek, J. et al. Polyclonal regulatory T cell manufacturing under cGMP: a decade of experience. Front. Immunol. 12, 744763 (2021).","journal-title":"Front. Immunol."},{"key":"2910_CR459","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","volume":"127","author":"CG Brunstein","year":"2016","unstructured":"Brunstein, C. G. et al. Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. Blood 127, 1044\u20131051 (2016).","journal-title":"Blood"},{"key":"2910_CR460","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ccell.2023.04.003","volume":"41","author":"A Obradovic","year":"2023","unstructured":"Obradovic, A. et al. Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators. Cancer Cell 41, 933\u2013949.e911 (2023).","journal-title":"Cancer Cell"},{"key":"2910_CR461","first-page":"eabj9836","volume":"7","author":"RN Ramirez","year":"2022","unstructured":"Ramirez, R. N. et al. FoxP3 associates with enhancer-promoter loops to regulate T(reg)-specific gene expression. Sci. Immunol. 7, eabj9836 (2022).","journal-title":"Sci. Immunol."},{"key":"2910_CR462","doi-asserted-by":"publisher","first-page":"e12361","DOI":"10.1002\/jev2.12361","volume":"12","author":"R Huang","year":"2023","unstructured":"Huang, R. et al. Plant exosomes fused with engineered mesenchymal stem cell-derived nanovesicles for synergistic therapy of autoimmune skin disorders. J. Extracell. Vesicles 12, e12361 (2023).","journal-title":"J. Extracell. Vesicles"},{"key":"2910_CR463","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.biomaterials.2015.04.003","volume":"59","author":"MD McHugh","year":"2015","unstructured":"McHugh, M. D. et al. Paracrine co-delivery of TGF-\u03b2 and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells. Biomaterials 59, 172\u2013181 (2015).","journal-title":"Biomaterials"},{"key":"2910_CR464","doi-asserted-by":"publisher","first-page":"912594","DOI":"10.3389\/fimmu.2022.912594","volume":"13","author":"M Haist","year":"2022","unstructured":"Haist, M., Mail\u00e4nder, V. & Bros, M. Nanodrugs targeting T cells in tumor therapy. Front. Immunol. 13, 912594 (2022).","journal-title":"Front. Immunol."},{"key":"2910_CR465","doi-asserted-by":"publisher","first-page":"e2311566120","DOI":"10.1073\/pnas.2311566120","volume":"120","author":"D Ramanan","year":"2023","unstructured":"Ramanan, D. et al. Homeostatic, repertoire and transcriptional relationships between colon T regulatory cell subsets. Proc. Natl. Acad. Sci. USA. 120, e2311566120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2910_CR466","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01450-3","volume":"20","author":"ML Dixon","year":"2021","unstructured":"Dixon, M. L. et al. Remodeling of the tumor microenvironment via disrupting Blimp1(+) effector Treg activity augments response to anti-PD-1 blockade. Mol. Cancer 20, 150 (2021).","journal-title":"Mol. Cancer"},{"key":"2910_CR467","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-021-00519-w","volume":"21","author":"AR Mu\u00f1oz-Rojas","year":"2021","unstructured":"Mu\u00f1oz-Rojas, A. R. & Mathis, D. Tissue regulatory T cells: regulatory chameleons. Nat. Rev. Immunol. 21, 597\u2013611 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"2910_CR468","doi-asserted-by":"publisher","first-page":"eaaw2910","DOI":"10.1126\/sciimmunol.aaw2910","volume":"4","author":"LA Kalekar","year":"2019","unstructured":"Kalekar, L. A. et al. Regulatory T cells in skin are uniquely poised to suppress profibrotic immune responses. Sci. Immunol. 4, eaaw2910 (2019).","journal-title":"Sci. Immunol."},{"key":"2910_CR469","doi-asserted-by":"publisher","first-page":"eaao6923","DOI":"10.1126\/sciimmunol.aao6923","volume":"3","author":"N Malhotra","year":"2018","unstructured":"Malhotra, N. et al. ROR\u03b1-expressing T regulatory cells restrain allergic skin inflammation. Sci. Immunol. 3, eaao6923 (2018).","journal-title":"Sci. Immunol."},{"key":"2910_CR470","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1774-x","volume":"17","author":"HK Min","year":"2019","unstructured":"Min, H. K. et al. Protein inhibitor of activated STAT3 reduces peripheral arthritis and gut inflammation and regulates the Th17\/Treg cell imbalance via STAT3 signaling in a mouse model of spondyloarthritis. J. Transl. Med. 17, 18 (2019).","journal-title":"J. Transl. Med."},{"key":"2910_CR471","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.bbrc.2015.11.030","volume":"468","author":"M Asakawa","year":"2015","unstructured":"Asakawa, M. et al. A novel JAK-STAT inhibitor, 2-[(3-Carbamoyl-2-thienyl)amino]-2-oxoethyl(2,6-dichlorophenyl)acetate, suppresses helper T cell differentiation in vitro and collagen-induced arthritis in vivo. Biochem. Biophys. Res. Commun. 468, 766\u2013773 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2910_CR472","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ni.2499","volume":"14","author":"MG Strainic","year":"2013","unstructured":"Strainic, M. G. et al. Absence of signaling into CD4\u207a cells via C3aR and C5aR enables autoinductive TGF-\u03b21 signaling and induction of Foxp3\u207a regulatory T cells. Nat. Immunol. 14, 162\u2013171 (2013).","journal-title":"Nat. Immunol."},{"key":"2910_CR473","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.phymed.2016.01.002","volume":"23","author":"SM Lim","year":"2016","unstructured":"Lim, S. M. et al. Neomangiferin modulates the Th17\/Treg balance and ameliorates colitis in mice. Phytomedicine 23, 131\u2013140 (2016).","journal-title":"Phytomedicine"},{"key":"2910_CR474","doi-asserted-by":"publisher","first-page":"101454","DOI":"10.1016\/j.jcmgh.2024.101454","volume":"19","author":"Y Shen","year":"2024","unstructured":"Shen, Y. et al. Sorafenib promotes Treg cell differentiation to compromise its efficacy via VEGFR\/AKT\/Foxo1 signaling in hepatocellular carcinoma. Cell. Mol. Gastroenterol. Hepatol. 19, 101454 (2024).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"2910_CR475","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1002\/ptr.7988","volume":"37","author":"W Hui","year":"2023","unstructured":"Hui, W. et al. Ginkgo biloba extract promotes Treg differentiation to ameliorate ischemic stroke via inhibition of HIF-1\u03b1\/HK2 pathway. Phytother. Res. 37, 5821\u20135836 (2023).","journal-title":"Phytother. Res."},{"key":"2910_CR476","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0297-3","volume":"9","author":"Q Lv","year":"2018","unstructured":"Lv, Q. et al. Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD(+)\/SIRT1\/SUV39H1\/H3K9me3 signaling pathway. Cell Death Dis. 9, 258 (2018).","journal-title":"Cell Death Dis."},{"key":"2910_CR477","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.immuni.2021.04.014","volume":"54","author":"C Procaccini","year":"2021","unstructured":"Procaccini, C. et al. Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential. Immunity 54, 1543\u20131560.e1546 (2021).","journal-title":"Immunity"},{"key":"2910_CR478","doi-asserted-by":"publisher","first-page":"e48052","DOI":"10.15252\/embr.201948052","volume":"21","author":"AC Court","year":"2020","unstructured":"Court, A. C. et al. Mitochondrial transfer from MSCs to T cells induces Treg differentiation and restricts inflammatory response. EMBO Rep. 21, e48052 (2020).","journal-title":"EMBO Rep."},{"key":"2910_CR479","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1053\/j.gastro.2022.10.011","volume":"164","author":"GP Ramos","year":"2023","unstructured":"Ramos, G. P. et al. G9a modulates lipid metabolism in CD4 T cells to regulate intestinal inflammation. Gastroenterology 164, 256\u2013271.e210 (2023).","journal-title":"Gastroenterology"},{"key":"2910_CR480","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.4049\/jimmunol.180.5.2757","volume":"180","author":"X Luo","year":"2008","unstructured":"Luo, X. et al. Cutting edge: TGF-beta-induced expression of Foxp3 in T cells is mediated through inactivation of ERK. J. Immunol. 180, 2757\u20132761 (2008).","journal-title":"J. Immunol."},{"key":"2910_CR481","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02477-z","volume":"19","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. Melatonin, an endogenous hormone, modulates Th17 cells via the reactive-oxygen species\/TXNIP\/HIF-1\u03b1 axis to alleviate autoimmune uveitis. J. Neuroinflammation 19, 124 (2022).","journal-title":"J. Neuroinflammation"},{"key":"2910_CR482","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1182\/blood-2018-07-863233","volume":"133","author":"A Daenthanasanmak","year":"2019","unstructured":"Daenthanasanmak, A. et al. Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice. Blood 133, 266\u2013279 (2019).","journal-title":"Blood"},{"key":"2910_CR483","doi-asserted-by":"publisher","first-page":"eaaw2707","DOI":"10.1126\/sciimmunol.aaw2707","volume":"4","author":"M Akamatsu","year":"2019","unstructured":"Akamatsu, M. et al. Conversion of antigen-specific effector\/memory T cells into Foxp3-expressing T(reg) cells by inhibition of CDK8\/19. Sci. Immunol. 4, eaaw2707 (2019).","journal-title":"Sci. Immunol."},{"key":"2910_CR484","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s10495-019-01548-6","volume":"24","author":"P Dinesh","year":"2019","unstructured":"Dinesh, P. & Rasool, M. Berberine mitigates IL-21\/IL-21R mediated autophagic influx in fibroblast-like synoviocytes and regulates Th17\/Treg imbalance in rheumatoid arthritis. Apoptosis 24, 644\u2013661 (2019).","journal-title":"Apoptosis"},{"key":"2910_CR485","doi-asserted-by":"publisher","first-page":"e20251635","DOI":"10.1084\/jem.20251635","volume":"223","author":"M Arai","year":"2026","unstructured":"Arai, M. et al. Oral antigen exposure under costimulation blockade induces Treg cells to establish immune tolerance. J. Exp. Med. 223, e20251635 (2026).","journal-title":"J. Exp. Med."},{"key":"2910_CR486","doi-asserted-by":"publisher","first-page":"e53475","DOI":"10.15252\/embr.202153475","volume":"23","author":"H Zhou","year":"2022","unstructured":"Zhou, H. et al. A peptide encoded by pri-miRNA-31 represses autoimmunity by promoting T(reg) differentiation. EMBO Rep. 23, e53475 (2022).","journal-title":"EMBO Rep."},{"key":"2910_CR487","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70047","volume":"14","author":"Q Huang","year":"2024","unstructured":"Huang, Q. et al. Bioactive compounds from ShenFuShanYuRou decoction enhance Treg cell function against hemorrhagic shock injury via Stat1- and Gbp5-dependent FOXP3 induction. Clin. Transl. Med. 14, e70047 (2024).","journal-title":"Clin. Transl. Med."},{"key":"2910_CR488","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","volume":"395","author":"B Sawitzki","year":"2020","unstructured":"Sawitzki, B. et al. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2\u2009A trials. Lancet 395, 1627\u20131639 (2020).","journal-title":"Lancet"},{"key":"2910_CR489","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/imr.12801","volume":"292","author":"JM Gauthier","year":"2019","unstructured":"Gauthier, J. M. et al. The emerging role of regulatory T cells following lung transplantation. Immunol. Rev. 292, 194\u2013208 (2019).","journal-title":"Immunol. Rev."},{"key":"2910_CR490","doi-asserted-by":"publisher","first-page":"109620","DOI":"10.1016\/j.intimp.2022.109620","volume":"115","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y. et al. ADAR1 improved Treg cell function through the miR-21b\/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Int. Immunopharmacol. 115, 109620 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"2910_CR491","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","volume":"186","author":"RD Michalek","year":"2011","unstructured":"Michalek, R. D. et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+T cell subsets. J. Immunol. 186, 3299\u20133303 (2011).","journal-title":"J. Immunol."},{"key":"2910_CR492","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/nm.3704","volume":"20","author":"L Berod","year":"2014","unstructured":"Berod, L. et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20, 1327\u20131333 (2014).","journal-title":"Nat. Med."},{"key":"2910_CR493","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ni.3577","volume":"17","author":"VA Gerriets","year":"2016","unstructured":"Gerriets, V. A. et al. Foxp3 and Toll-like receptor signaling balance T(reg) cell anabolic metabolism for suppression. Nat. Immunol. 17, 1459\u20131466 (2016).","journal-title":"Nat. Immunol."},{"key":"2910_CR494","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cmet.2018.09.020","volume":"29","author":"L Li","year":"2019","unstructured":"Li, L. et al. TLR8-mediated metabolic control of human treg function: a mechanistic target for cancer immunotherapy. Cell Metab. 29, 103\u2013123.e105 (2019).","journal-title":"Cell Metab."},{"key":"2910_CR495","doi-asserted-by":"publisher","first-page":"1433989","DOI":"10.3389\/fimmu.2024.1433989","volume":"15","author":"S Rokade","year":"2024","unstructured":"Rokade, S., Damani, A. M., Oft, M. & Emmerich, J. IL-2 based cancer immunotherapies: an evolving paradigm. Front. Immunol. 15, 1433989 (2024).","journal-title":"Front. Immunol."},{"key":"2910_CR496","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1073\/pnas.93.5.2077","volume":"93","author":"MC Friedmann","year":"1996","unstructured":"Friedmann, M. C., Migone, T. S., Russell, S. M. & Leonard, W. J. Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl. Acad. Sci. USA. 93, 2077\u20132082 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02910-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02910-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02910-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:01:42Z","timestamp":1788220902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02910-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":496,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2910"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02910-2","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"356"}}